«Inizia una nuova era di fare impresa», è con queste parole che StarsUp, primo gestore in Italia e nel mondo autorizzato alla gestione di piattaforme per la raccolta online di capitale di rischio, definisce la portata innovatrice dello strumento che secondo molti rivoluzionerà il modo di fare impresa: il crowdfunding. A sei anni dallo scoppio della crisi finanziaria, i suoi effetti sono ancora oggi visibili e la ripresa dell'economia mondiale tarda ad iniziare, soprattutto a causa dei meccanismi di credit crunch innescati dalla crisi stessa. Infatti, la stretta creditizia messa in atto dalle banche e dagli altri attori del sistema finanziario, non permette alle imprese di reperire i fondi necessari per realizzare nuovi investimenti. Se da un lato le imprese non riescono più ad accedere ai cosiddetti "finanziamenti dall'alto", dall'altro un nuovo e potente strumento, il crowdfunding, letteralmente "finanziamento dalla folla", offre una soluzione speculare, ossia il "finanziamento dal basso": le imprese possono reperire i mezzi necessari a realizzare i propri progetti e gli investimenti pianificati grazie ai piccoli contributi di una moltitudine di persone, le quali, con un semplice click, possono finanziare tramite internet i progetti e le imprese ritenute più valide e meritevoli. In Italia il fenomeno del crowdfunding è diventato oggetto di grande attenzione in seguito all'emanazione del Decreto Crescita Bis nell'ottobre 2012 e del successivo Regolamento Consob: il nostro Paese, infatti, è stato il primo al mondo ad aver introdotto una specifica regolamentazione in merito al fenomeno, in particolare per quanto riguarda la fattispecie dell'equity crowdfunding. Sulla base delle considerazioni appena fatte, nel corso del presente lavoro ci si propone di condurre un'analisi del fenomeno del crowdfunding, con particolare riguardo al suo sviluppo in Italia, al fine di delineare le peculiarità e i tratti distintivi di quello che può essere considerato uno strumento potenzialmente capace di gettare le basi per la ripresa economica nel nostro Paese e non solo. L'analisi in questione verterà anzitutto sulla descrizione generale del fenomeno del crowdfunding, delle sue origini e della sua evoluzione nel tempo, evoluzione che ha condotto allo sviluppo di quattro diversi modelli: donation, reward, lending ed equity. Al fine di comprendere se il crowdfunding possa essere effettivamente un valido strumento per favorire la ripresa economica, si cercherà altresì di individuare i benefici dello stesso per il sistema economico, per le imprese e per gli investitori, nonché i risultati e le cifre raccolte fino ad oggi dall'industria mondiale del crowdfunding. A seguito di questa parte introduttiva e descrittiva, come anticipato in precedenza, con la presente trattazione ci si prefigge l'obiettivo di approfondire lo studio del fenomeno del crowdfunding relativamente al suo sviluppo in Italia, primo Paese al mondo ad aver introdotto una specifica disciplina regolamentare, seppur in merito solo ad uno specifico modello di crowdfunding, l'equity model. L'intervento del legislatore italiano si inserisce in un contesto caratterizzato da diverse criticità, quali l'elevato tasso di disoccupazione, la contrazione dei consumi, le difficoltà delle imprese ad accedere al credito bancario e agli altri canali di funding (mercati borsistici, fondi di venture capital, ecc.), per cui il 18 ottobre 2012 è stato emanato il Decreto Legge n. 179, contenente una serie di interventi volti a favorire la ripresa economica, l'occupazione e l'innovazione. Tra le misure previste dal Decreto, particolare attenzione è stata data ad un particolare tipo di imprese, le cosiddette start-up innovative, le quali, se in possesso dei requisiti necessari stabiliti dal Decreto stesso per potersi definire tali, godono di una disciplina di favore con agevolazioni fiscali, deroghe la diritto societario, al diritto fallimentare, ecc., ma soprattutto possono raccogliere capitale di rischio, offrendo proprie quote o azioni tramite apposite piattaforme on-line, pertanto tramite l'equity crowdfunding. Il Decreto ha quindi delegato la Consob a produrre l'apposita regolamentazione secondaria al fine di disciplinare questo tipo di attività, la quale viene riservata a banche e a imprese di investimento, nonché ai soggetti iscritti in una apposito registro tenuto dalla Consob (cosiddetti "gestori ordinari"). Analizzati i contenuti dell'apposito Regolamento introdotto dalla Consob il 26 giugno 2013, si cercherà di individuare le principali ed eventuali criticità emerse dalla disamina della disciplina sull'equity crowdfunding e di condurre un'analisi comparativa con soluzioni normative adottate dai principali Paesi europei, quali Inghilterra, Germania, Francia, e dagli USA. Nonostante il crowdfunding sia diventato in Italia argomento di grandi dibattiti a seguito dell'introduzione della specifica regolamentazione, esso non è comunque un fenomeno del tutto nuovo nel nostro Paese. Ai fini del presente lavoro, pertanto, si ritiene doveroso sondare quali siano i principali modelli di crowdfunding affermatisi in Italia ed esaminare lo stato dell'arte dei portali on-line che ad oggi sono presenti sul mercato italiano. Sulla base dell'analisi delle piattaforme italiane, per una corretta comprensione del crowdfunding in Italia non si può prescindere dallo studio di un caso specifico, ossia quello relativo a StarsUp S.r.l., primo gestore ad aver ottenuto in Italia l'autorizzazione da parte della Consob per la gestione di un portale di equity crowdfunding. Oltre ad un primato italiano, StarsUp vanta anche un primato a livello mondiale, infatti, come ripetuto più volte, l'Italia è il primo Paese al mondo ad aver regolamentato l'equity crowdfunding. Ci si propone, dunque, di analizzare le peculiarità e le modalità operative di StarsUp, con particolare attenzione all'iter che le start-up innovative devono seguire per pubblicare un progetto e alle fasi che invece caratterizzano il percorso dell'investitore per aderire ad offerta pubblicata sul portale. Infine, si ritiene importante completare lo studio di StarsUp attraverso il confronto con le caratteristiche e le modalità operative di un altro portale, Unicaseed, il quale, sebbene nasca dopo, è il primo portale italiano ad esser stato lanciato da un intermediario finanziario, Unicasim S.p.A., e soprattutto il primo sul quale è stata avviata e conclusa con successo una campagna di equity crowdfunding.
This collection contains a diary, personal letters and photos of Edmond Arthur Littlefield principally from his service in the American Field Service during World War I. Other items include pre and post WWI letters and photos. ; Diary is 8 1/2 x 6 in. green covered composition book; letters are sheets of 6 x 9 in. paper; photographs are 2 x 3 in. ; Cunard Bulletin.R. M. S. " ANDANIA." TUESDAY, 2nd October, 1917. AMERICA'S OFFICIAL PEACE REPRESENTATIVE. PRELIMINARY MEASURES ONLY. Washington. Colonel Emhouse of Texas and New York,. one of President Wilson's closest friends, will head the Peace Mission of the United States when one is named to take up with other belligerent representatives the intricate questions to be settled before peace is finally secured. This was the official interpretation placed oil the naming of the Colonel, who has been instructed to gather political, commercial and geographical data to be utilized when a peace conference is held. This does not in any way indicate that hostilities may end soon officials state.There are no British or French official messages to hand from the Western front. FURTHER ITALIAN SUCCESS. Home, September 30th. The Italians, have gained further ground and repulsed the enemy. General Cardorna has rectified his lines by a surprise attack near Monte San Gabrielle.The War Office report reads: " Italian troops made an attack 011 the front above Gorizia yesterday and gained ground which was held in the face of repeated fierce counter attacks." OUST LA FOLLETTE MOTION Washington, September 29th. The move to oust Senator La Follette of Wisconsin, from the United States Senate opened today with the introduction by Senator Kellogg of. Minnesota, of resolutions adopted by the Public Safety Commission of Minnesota demanding Senator La Follett's expulsion. ALLIES TO TIGHTEN THE BLOCKADE OF GERMANY. London, September 30th. A still more vigorous blockade of Germany is to be enforced by the entente allies; as a result of the Conference between Lord Robert Cecil, the British Minister of Blockade with the French Minister of Blockade. Today King George signed a proclamation prohibiting the exportatation of certain articles to Sweden and Holland. His Majesty's approval was also given to other measures to make it more difficult for the enemy in the future to obtain supplies through the neutral countries. JAPAN AND THE MONROE DOCTRINE. New York, September 30th. In the far east the Monroe doctrine guards China says Viscount Ishiu. Speaking amid cheers at a New York banquet in his honour, he declared: " Neither Nippon aggression nor aggression against the territory or independence of China by any other power will be tolerated, and he pledged Japan not to attempt any aggression on her part. The head of the Japanese Mission blamed Germany for the distrust that was prevalent, and stated that he could see the whole world set free by the Allies. " RUSSIAN OFFICIAL.The Russian official communique states: " We pressed enemy's advanced posts back 1000 yards."CUNARD BULLETIN ANOTHER AIR RAID ON LONDON London, September 30th. London was again raided by aeroplanes on the night of September 29th. Three groups approached the city from different directions, but each group was broken up by the defences through which only two of at most three machines managed to penetrate. A fourth group which approached later was also driven off. Bombs were dropped at various places in Kent and Essex. The casualties reported number eleven killed and eighty-two injured. A heavy barrage by our anti aircraft guns was very effective against the enemy. AMERICAN WAR TAX BILL. The House and Senate conferees on the war tax bill reached a final agreement on the measure late yesterday, and the report will be presented to the House tomorrow. The conferees made no change in the approximate levies on excess war profits and incomes. They provided, however, a new system of calculating excess profits. Both Senate and House Committees say the compromise is better than the original draft. NEW YORK'S NEW COLLECTOR. Washington, September 29th The Senate today confirmed the appointment of Mr. Byron Newton, formerly Assistant Secretary of the Treasury as Collector of Customs of the port of New York. Mr. Newton succeeds Mr. Dudley Field M alone. AMERICAN ARMY NEWS. Washington, September 30th. Brigadier General John A. Le Jenn, for three years Senior Assistant to the Major General Commandant at Marine Corps Headquarters has been ordered to command the Marine Cantonment at Quantico, Virginia. NEW SEAMEN'S CLUB FOR NEW YORK. New York. October 1st.The new Clubhouse for the use of American Naval Seamen was opened today at West End Avenue and 93rd Street. The Clubhouse was donated by Professor Blander Matthews and will be directed by the National Special Aid Commission as part of its string of Soldier's and Sailor's Home Clubs. STORM SWEEPS MISSISSIPPI AND FLORIDA COASTS. New Orleans, September 30th. Rescue steamers were being made ready here to-day to go to the relief of Pensacola, Florida, which was cut off from the outside world by the hurricane which has. swept the vicinity. Every attempt is being made to reach the isolated city. Biloxi, Harrison Co., a gulf port, and other Southern Mississippi towns in the storm's path weathered the seventy five mile gale with a few unroofed houses and other slight damage. Subscription lists and other charitable schemes have been started for the relief of the homeless. WAR RELIEF FUND. The American Women's War Relief Fund has equipped and entirely financed a Clinical Hospital of 250 beds at Paignton, Devonshire, and has organized an Economical Relief Scheme, where many women thrown out of employment directly owing to the war, are given employment. Funds are urgently needed to carry on these objects. All donations will be gratefully received by the Hon. Treasurer, WALTER S. H. BURNS, 58, Grosvenor Gardens, LONDON. Offices: 31, Old Burlington Street, London, Eng. where all particulars will be gladly given.
This document presents findings from a study conducted to identify and document ongoing public-private partnerships (PPPs) for improving access to quality laboratory services, especially for the poor, in the East Africa region. The East, Central, and Southern Africa Health Community (ECSA-HC) coordinated the study along with the partner states in the East African Community participating in the World Bank funded East Africa Public Health Laboratory Networking Project (EAPHLNP). The authors implemented key informant interviews in Kenya, Rwanda, Tanzania and Uganda, and analyzed the information gathered from the interviews which is presented in this report. The study finds that while there are numerous examples of public-private collaboration across all four countries, the number of formals PPPs remains scarce. The most common form of PPP is placement, whereby privately owned laboratory equipment in leased by public facilities. Most other instances of collaboration between public and private partners, did not meet the formal definition of a PPP. Key stakeholders from both public and private institutions showed a keen interest in learning about and setting up more, diverse kinds of PPPs. The numerous informal and semi-formal arrangements that currently exist all represent opportunities for establishing formal PPPs in accordance with global best practices.
Aim: The aim of this thesis was to obtain an overview over the options of Nordic infertile couples regarding assisted reproduction treatment, and to follow couples' arguments and decision-making process to make relevant decisions about these options. Methods: Quantitative and qualitative methods were used. The study design was inspired by Ecological systems theory, where data was gathered from laws and regulations (macro-level), fertility clinics (meso-level) and the couples using these options (micro-level). Study I consists of results from a review of the legislations in the five Nordic countries and results from a questionnaire that was sent to all fertility clinics to gather information about available options. Papers II and III present the findings of the interviews with 22 Nordic couples, after their first appointment with a specialist at the fertility clinic. The couples came from Denmark (3), Finland (6), Iceland (3), Norway (4) and Sweden (6). Study IV presents the findings of follow-up interviews with the same couples approximately three years later. For the qualitative study the tools of Grounded Theory were used. Findings: In Study I it was found that Nordic couples generally have good access to assisted reproductive technology treatments (ART), although it is not evenly distributed and there are restrictions related to certain criteria, such as age. There are national differences in the legislations, especially regarding gamete donation. These differences open up for cross-border reproductive care, andmore than one third of the fertility clinics offered treatment to people from other countries. Study II describes the decision-making process of the couples when determining the "right time" to try for a child. The couples mention the need to feel prepared for parenthood; such as a stable social situation, and once they felt prepared they became more susceptible to decision-making catalysts, such as influence from friends and family. Fear of infertility made the couple accelerate their decision regardless of preparation. In Study III the decision-making process of seeking medical help is illustrated. The core category was "negotiation and re-negotiation". The process of decision-making is first to accept that they have a problem in common, secondly that they need knowledge and finally to take action and get help. Study IV deals with the decision-making process during treatments. Of 22 couples, 17 had succeeded at becoming parents after approximately three years, three couples were still trying and two had not decided how to continue. The core category was "maintaining control in an uncertain situation". The couples tried to keep focus on the goal and to learn to deal with the new world with various methods. Conclusions:The structure of and the access to service for infertile couples differ between the Nordic countries. Some of the differences, e.g. regarding subsidy systems and waiting time, affected the decision making process since they could mean a delay in the treatment process or whether a private or public clinic was chosen. Additionally, a couple consists of two individuals with independent decision-making processes, which makes joint decision-making difficult and time-consuming. The couples have to negotiate their way to a consensus and are constantly confronted with new choices they need to re-negotiate on. The decision-making process, when dealing with infertility, is not a straight line, but rather a chain of small decisions affected by feelings, context and situation ; Markmið: Markmið rannsóknarinnarvar að ná yfirsýn yfir þeim tæknifrjóvgunarmöguleikum sem norrænum pörum sem kljást við ófrjósemi stendur til boða, og að fylgja rökleiðslu þeirra og ákvarðanatökuferli sem tengist þessum möguleikum. Aðferð: Megindlegum og eigindlegum aðferðum var beitt.Hönnun rannsóknarinnarsótti innblástur til Ecological systems theory, með söfnun gagna frálögum og reglugerðum (macro-stig), tæknifrjóvgunarstofum (meso-stig) og frá pörunum sem nýttu sérþessa möguleika (micro-stig). Grein Iinniheldur niðurstöður rýni á reglugerðum Norðurlandanna fimm, ásamt niðurstöðum spurningalista sem sendur var öllum tæknifrjóvgunarstofum til að fá upplýsingar um þá möguleika sem stóðu til boða. GreinarII og III kynna niðurstöður úr viðtölum við 22 norræn pör sem fórufram eftir fyrsta tíma þeirra hjá sérfræðingi á tæknifrjóvgunarstofu. Pörin komu frá Danmörku (3), Finnlandi (6), Íslandi (3), Noregi (4) og Svíþjóð (6). Grein IV kynnir niðurstöður framhaldsviðtala við sömu pör sem fóru fram u.þ.b. þremur árum síðar. Fyrir eigindlega hluta rannsóknarinnar var aðferðum úr Grounded theory beitt. Niðurstöður: Grein Isýndi fram á að aðgengi norrænna para að tæknifrjóvgunarmeðferðum er alla jafna gott. Þó er aðgengið er ekki jafndreift og það eru hömlur sem tengjast tilteknum skilyrðum, svo sem aldri. Það er munur á reglugerðum landanna, sérstaklega hvað snýr að kynfrumugjöf. Þessi mismunur opnar fyrir tæknifrjóvgunarþjónustu yfir landamæri, en meira en þriðjungur tæknifrjóvgunarstofa buðu þjónustu sína fólki frá öðrum löndum. Grein II lýsir ákvarðanatökuferli paranna þegar þau ákvarða hvenær sé "réttur tími" til að reyna að eignast barn. Pörin nefndu þörfina fyrir að finnast þau vera undirbúin fyrir foreldrahlutverkið, svo sem að hafa trygga félagslega stöðu, en að því búnu urðu þau móttækilegri fyrir ákvarðanatökuhvötum, svo sem áhrifum frá vinum og fjölskyldu. Óttivið ófrjósemi olli því að pörin flýttu ákvörðun sinni, óháð öðrum þáttum. Grein III varpar ljósi á ákvarðanatökuferlið sem leiðir til þess að leitað er aðstoðar sérfræðinga. Kjarnaflokkurinn (e. core category) var "að semja og endursemja". Ferli ákvarðanatökunnar hefst með því að parið þarf að sætta sig viðað þau eigi við sameiginlegt vandamál að stríða, því næst þurfa þau að afla sér vitneskju, og loks að bregðast við ogleita hjálpar. Grein IV fjallar um ákvarðanatökuferlið meðan á meðferð stendur. Af 22 pörum, þá hafði 17 tekist að verða foreldrar eftir þrjú ár, þrjú pör voru enn að reyna og tvö pör höfðu ekki tekið ákvörðun um framhaldið. Kjarnaflokkurinn var " að halda stjórn í ótryggum aðstæðum". Pörin reyndu að einblína á markmiðið og að nota ýmsar aðferðir til þess að höndla nýjar aðstæður. Samantekt: Það er munur á uppbyggingu og aðgengi að þjónustu fyrir ófrjó pör milli Norðurlandanna. Sumir þessara mismunandi þátta, t.d. niðurgreiðslur og biðtími, höfðu áhrif á ákvarðanatökuferlið þar sem þeir gátu tafið meðferðina eða ráðið því hvort parið leitaði til einkastofu eða opinberrar stofnunar. Par samanstendur af tveimur einstaklingumhvor um sig með eigiðákvarðanatökuferli, en það gerir sameiginlega ákvarðanatöku erfiða og tímafreka. Parið verður að semja til að komast að sameiginlegri niðurstöðu, en þarf síðan í sífellu að endursemja um nýja möguleika sem koma fram. Ákvarðanatökuferlið eins og það snýr að ófrjósemi er ekki bein lína,heldur er það keðja af litlum ákvörðunum sem mótast af tilfinningum, samhengi og aðstæðum.
[SPA] El papel del sector fundacional español, en términos de organizaciones sin fines de lucro, es canalizar los esfuerzos privados en beneficio de interés general, donde el objetivo principal no es obtener la rentabilidad, como en el caso de las empresas comerciales, pero para lograr generales objetivos de interés. Por lo tanto, se presenta como una fórmula ideal para llevar a cabo el emprendimiento social, especialmente en el actual momento de crisis global, donde se llega a cuestionar el funcionamiento y la capacidad del Estado de Bienestar como lo conocemos. El sector de las fundaciones españolas representa, desde el punto de vista, una parte muy importante de la economía del sector social cuantitativa y cualitativa. Su creciente importancia se refleja en el número de organizaciones existentes, el empleo que generan, las necesidades sociales que cubren y el número de beneficiarios a las que sirven. Por esta razón, el conocimiento y el desarrollo de esta figura en un nivel jurídico, económico, financiero, social, descriptiva y empírica, en su conjunto, es una necesidad de entenderse en un marco de mediano y largo plazo. Fundaciones normalmente obtienen recursos y financiación a través de subvenciones o donaciones y legados de fuentes privadas de gobierno. Por lo tanto, los donantes y la demanda general del público cada vez más la transparencia de la información económica y financiera, y más mecanismos de control de fundaciones como la de todas las otras organizaciones sin fines de lucro, a fin de garantizar el uso adecuado de los recursos que la directa o indirectamente dar a ellos. De esta manera, la evidente necesidad de evaluar su actividad con el objetivo de mejorar su rendimiento y de asegurar a sus fundadores, una ejecución adecuada de los recursos surge. En este sentido, es precisamente desde el campo de la contabilidad de donde tienen que responder a la necesidad de proporcionar información económica y financiera de estas organizaciones de funcionamiento y las actividades de una manera adaptada a sus objetivos y para la sociedad y los grupos de interés demandas. Sin embargo, no ha sido una tarea fácil a lo largo de su historia, debido a que varias reformas contables han tenido que producirse hasta una configuración de modelo de contabilidad adecuados a la realidad económica de este tipo de organizaciones se ha alcanzado. Sin embargo, esta información no es suficiente si el objetivo es descubrir el alcance de su actuación en la gestión de recursos para el cumplimiento de sus fines de interés general, en cuyo caso hay que recurrir a otras herramientas para complementar esa información. La razón de esta Tesis es, dada la importancia que creemos que el sector de la fundación tiene en España, para realizar una-económico-financiera legal estudio, para mostrar sus principales escalas y su importancia como generador de empleo, que culminó en un estudio para evaluar el rendimiento de 260 cuidado, la educación y las fundaciones culturales mediante la aplicación de una técnica no paramétrica saber Análisis Envolvente de Datos (DEA). Esta técnica, desarrollado por Charnes et. al., (1978), se puede determinar la frontera de eficiencia de las "mejores prácticas" de las unidades evaluadas mediante un modelo de optimización matemática, y también nos permite estudiar el cambio de la productividad mediante el Índice de Productividad Malmquist total de los factores en base a la metodología DEA ( Färe et al., 1994). El estudio se complementa con un análisis de la eficiencia del programa y un análisis de la DEA en dos etapas usando un modelo de regresión logística para evaluar la posible asociación de covariables relevantes en la fundación del sector (sin fines de lucro), a saber (Charnes et al., 1981): el tamaño, la liquidez , la deuda, la antigüedad, los voluntarios, los excedentes, dotaciones y tamaño de la estructura de gobierno. Esto nos permite comparar con el desempeño de estas organizaciones como previamente calculado. Bajo esta motivación y estímulo para profundizar en el estudio del sector de las fundaciones en España, en esta tesis se propone una serie de objetivos básicos que se alcanzan a lo largo de los siete capítulos en los que se estructura el estudio: el primer capítulo comienza con el objetivo de acercarse la conceptualización del Tercer Sector y el papel que las fundaciones tienen en este ámbito; el segundo capítulo persigue hacer un estudio de este tipo de organizaciones desde una perspectiva jurídica; el tercero tiene como objetivo desarrollar y analizar las necesidades de información económica y financiera de las fundaciones; en el cuarto capítulo el objetivo es analizar las actividades económicas de las fundaciones a través del cual se logran los fines de interés general de la organización; en el quinto se analizan los conceptos de eficiencia y productividad y la metodología en uso se justifica y desarrollado; el sexto capítulo se analizan los resultados del modelo de eficiencia y, por último, el capítulo séptimo summerises las conclusiones más importantes de la investigación. [ENG] The role of the Spanish foundation sector, in terms of non-profit organisations, is to channel private efforts for the benefit of general interest, where the main goal is not to obtain profitability, as in the case of trading companies, but to achieve general interest objectives. It is therefore presented as an ideal formula to accomplish social entrepreneurship, especially in the current global crisis moment, where we get to question the functioning and capacity of the Welfare State as we know it. The Spanish foundation sector represents, from a quantitative and qualitative point of view, a very important part of the Social Economy Sector. Its increasing importance is reflected by the number of organisations existing, the employment they generate, the social needs they cover and the number of beneficiaries they serve. For this reason, the knowledge and development of this figure at a legal, economic, financial, social, descriptive and empirical level, as a whole, is a need to be understood within a framework of medium and long term. Foundations typically obtain resources and funding through government grants or donations and bequests from private sources. Therefore, donors and the general public demand more and more transparency of economic and financial information, and more control mechanisms from foundations as from all other non-profit organisations, so as to ensure the proper use of the resources that the directly or indirectly give to them. In this way, the obvious need to evaluate their activity with the aim of improving their performance and of ensuring its funders an adequate implementation of resources arises. In this sense, it is precisely from the accounting field from where they have to respond to the need to provide economic and financial information on these organisations' operation and activities in a manner adapted to their goals and to the society and stakeholders' demands. However, it has not been an easy task throughout their history, because several accounting reforms have had to occur until an accounting model configuration suitable to the economic reality of such organisations has been reached. However, such information is not sufficient if the aim is to discover the extent of their performance in managing resources for the fulfillment of their general interest purposes, in which case we must resort to other tools to complement that information. The reason for this Thesis is, given the importance that we believe the foundation sector has in Spain, to perform a legal-economic-financial study, to show their main scales and their importance as a generator of employment, culminating in a study to evaluate the performance of 260 care, educational and cultural foundations by applying a non-parametric technique namely Data Envelopment Analysis (DEA). This technique, developed by Charnes et. al., (1978), can determine the efficiency frontier of "best practices" of the evaluated units using a mathematical optimization model, and it also allows us to study the productivity change using the Total Factor Productivity Malmquist Index based on the DEA methodology (Färe et al., 1994). The study is complemented by a programme efficiency analysis (Charnes et al., 1981) and a two-stage DEA analysis using a logit regression model to evaluate the possible association of relevant covariates in the foundation (nonprofit) sector, namely: size, liquidity, debt, antiquity, volunteers, surplus, endowments and size of governing structure. This enables us to compare with the performance of these organisations as previously calculated. Under this motivation and encouragement to deepen in the study of the foundation sector in Spain, in this Thesis we propose a set of basic objectives which are reached along the seven chapters in which the study is structured: the first chapter begins with the aim of approaching the conceptualization of the Third Sector and the role that foundations hold in this area; the second chapter pursues to make a study of such organisations from a legal perspective; the third one aims to develop and analyse the needs of economic and financial information of foundations; in the fourth chapter the goal is to analyse the economic activities of the foundations through which the general interest purposes of the organisation are achieved; in the fifth one the concepts of efficiency and productivity are analysed and the methodology in use is justified and developed; the sixth chapter analyses the results of the model of efficiency, and finally, the seventh chapter summerises the most important conclusions of the investigation. ; [ENG] The role of the Spanish foundation sector, in terms of non-profit organisations, is to channel private efforts for the benefit of general interest, where the main goal is not to obtain profitability, as in the case of trading companies, but to achieve general interest objectives. It is therefore presented as an ideal formula to accomplish social entrepreneurship, especially in the current global crisis moment, where we get to question the functioning and capacity of the Welfare State as we know it. The Spanish foundation sector represents, from a quantitative and qualitative point of view, a very important part of the Social Economy Sector. Its increasing importance is reflected by the number of organisations existing, the employment they generate, the social needs they cover and the number of beneficiaries they serve. For this reason, the knowledge and development of this figure at a legal, economic, financial, social, descriptive and empirical level, as a whole, is a need to be understood within a framework of medium and long term. Foundations typically obtain resources and funding through government grants or donations and bequests from private sources. Therefore, donors and the general public demand more and more transparency of economic and financial information, and more control mechanisms from foundations as from all other non-profit organisations, so as to ensure the proper use of the resources that the directly or indirectly give to them. In this way, the obvious need to evaluate their activity with the aim of improving their performance and of ensuring its funders an adequate implementation of resources arises. In this sense, it is precisely from the accounting field from where they have to respond to the need to provide economic and financial information on these organisations' operation and activities in a manner adapted to their goals and to the society and stakeholders' demands. However, it has not been an easy task throughout their history, because several accounting reforms have had to occur until an accounting model configuration suitable to the economic reality of such organisations has been reached. However, such information is not sufficient if the aim is to discover the extent of their performance in managing resources for the fulfillment of their general interest purposes, in which case we must resort to other tools to complement that information. The reason for this Thesis is, given the importance that we believe the foundation sector has in Spain, to perform a legal-economic-financial study, to show their main scales and their importance as a generator of employment, culminating in a study to evaluate the performance of 260 care, educational and cultural foundations by applying a non-parametric technique namely Data Envelopment Analysis (DEA). This technique, developed by Charnes et. al., (1978), can determine the efficiency frontier of "best practices" of the evaluated units using a mathematical optimization model, and it also allows us to study the productivity change using the Total Factor Productivity Malmquist Index based on the DEA methodology (Färe et al., 1994). The study is complemented by a programme efficiency analysis (Charnes et al., 1981) and a two-stage DEA analysis using a logit regression model to evaluate the possible association of relevant covariates in the foundation (nonprofit) sector, namely: size, liquidity, debt, antiquity, volunteers, surplus, endowments and size of governing structure. This enables us to compare with the performance of these organisations as previously calculated. Under this motivation and encouragement to deepen in the study of the foundation sector in Spain, in this Thesis we propose a set of basic objectives which are reached along the seven chapters in which the study is structured: the first chapter begins with the aim of approaching the conceptualization of the Third Sector and the role that foundations hold in this area; the second chapter pursues to make a study of such organisations from a legal perspective; the third one aims to develop and analyse the needs of economic and financial information of foundations; in the fourth chapter the goal is to analyse the economic activities of the foundations through which the general interest purposes of the organisation are achieved; in the fifth one the concepts of efficiency and productivity are analysed and the methodology in use is justified and developed; the sixth chapter analyses the results of the model of efficiency, and finally, the seventh chapter summerises the most important conclusions of the investigation. ; Universidad Politécnica de Cartagena
Die Inhalte der verlinkten Blogs und Blog Beiträge unterliegen in vielen Fällen keiner redaktionellen Kontrolle.
Warnung zur Verfügbarkeit
Eine dauerhafte Verfügbarkeit ist nicht garantiert und liegt vollumfänglich in den Händen der Herausgeber:innen. Bitte erstellen Sie sich selbständig eine Kopie falls Sie diese Quelle zitieren möchten.
Less than a year ago, I wrote of the almost certain regret that awaited the prosperous, urban, multiple‐degree‐holding types who voted for Gustavo Petro, Colombia's Chavista president. They thought they had supported a Nordic‐style social democrat—failing to notice that they had helped to elect a tropical socialist who, given his past as a guerrilla group member and Hugo Chávez supporter, was also a potential autocrat. Caveat emptor (or rather suffragator) indeed. But I never thought that voter's remorse would set in so quickly. Or so extremely. According to poll data from June 1, 2023, only 26 percent of Colombian citizens approved of Petro's performance as president. And this was before the scandal that shook the country's political scene last Sunday evening, when Semana magazine released a series of WhatsApp audio files sent by Armando Benedetti, Petro's former ambassador in Caracas, to Laura Sarabia, the president's former chief of staff. Among the least bombastic revelations is Benedetti's claim that Alfonso Prada, Petro's former interior minister, "stole the whole ministry with his wife." This implies massive levels of corruption around Petro, who came to power with an anti‐corruption agenda (quite cynically given his disreputable political alliances). Prada proceeded to sue Benedetti for libel. Petro's dwindling number of supporters may dismiss this as a politician's petty slander against a rival in the cabinet. Far more concerning for them—and for Petro—is Benedetti's matter‐of‐fact assertion to Sarabia that he himself obtained COP $15 billion (around USD $3.58 million at today's exchange rate) for Petro's 2022 presidential campaign, during which he served as the former candidate's right‐hand‐man and main political handler. Petro's campaign did not officially report any donation nearly as large. Its declared funds consisted mostly a series of bank loans, which were meant to be paid with the "reimbursement" sum that the Colombian state guarantees to candidates for each vote received in an election. In many countries, an insider's admission of how millions of undeclared dollars flowed into the president's campaign coffers would bring down the government. Alas, Colombia is not one of them. This is not due to a lack of unashamedly corrupt presidents; as I wrote recently in The Wall Street Journal, the opposite has been the case. Rather, since the 1950's, the Colombian elite's idiosyncratic approach to presidential corruption has followed the maxim, attributed to journalist Hernando Santos (1922–1999), that the trouble with overthrowing a president is that he may fall upon those doing the toppling. Already in Petro's case, the three‐member House of Representatives commission created to investigate Benedetti's statements includes two members of the president's own party. The enquiry will be a charade, which is a pity since the source of the undeclared campaign money is as important as the sum itself. In an interview, Benedetti told Semana that the money "did not come from entrepreneurs," meaning the legal business community. Suspicion has fallen on the Marxist guerrilla groups and other drug trafficking organizations, but also on the Venezuelan regime of Nicolás Maduro. Anonymous, the hacker group, claims that Maduro financed "part of the campaign of the current president of Colombia," but has not published evidence hitherto. What is certain is that, in regional terms, the Maduro regime has been the principal beneficiary of Petro's election. To begin with, Colombia recognized Maduro's presidency after a three‐and‐a‐half‐year hiatus, and Petro himself has met Maduro four times since his inauguration. His government, which opposes any future hydrocarbon exploration in Colombia despite dwindling reserves, has promoted the idea of importing Venezuelan natural gas. While Petro wages a political war against Colombia's key petroleum industry—crude oil has been the country's main legal export for decades—he lobbied President Joe Biden to end American sanctions against the Maduro regime. This would imply renewed Venezuelan oil exports to the U.S. market (even if socialism devastated Venezuela's oil industry well beyond immediate or even medium term repair). Petro's "shoot yourself in the foot / prosper‐thy‐neighbor" policy is devoid of any rationality. Unless, of course, Colombia's increasingly authoritarian president is somehow subject to the Venezuelan tyrant. Petro's eco‐fanatical crusade against the hydrocarbon industry is but one example of how his government is bent on destroying the few areas of the Colombian economy that are functional. Other examples include his plans to put the state in charge of centralized funding for the healthcare and pension systems, both of which are efficient—although certainly not perfect—thanks to private sector involvement and some degree of consumer choice. Where things are already problematic, Petro's policies would make them worse. For instance, he wants to make a rigid, overregulated labor market even less flexible and more hostile to businesses. Then there is the matter of rising insecurity, an old problem that, until recently, appeared mostly solved, only to resurface dangerously in the last year. Under Petro, illegal armed groups have expanded their power as they launch constant, deadly attacks against the armed forces and police. It all brings to mind the dark era of the late 1990's, when Colombia was on the verge of becoming a failed state as it came under siege from the FARC guerrillas, which are still up in arms despite the much‐touted "peace" agreement of 2016. Usually, a crisis in government breeds economic instability. Under Colombia's current government, however, the opposite has been the case. Since the Benedetti scandal broke, the peso rallied to reach its highest value against the dollar since mid‐2022, when Petro was about to win the presidential election. In October, two months after he took office, the peso reached an all‐time low against the dollar. Amid the current political turmoil, forward‐looking markets are anticipating the failure of Petro's legislative initiatives in health care, pensions, and labor law. Which is to say, there is speculation that Colombia's institutional framework has already survived Petro's statist onslaught. The weaker his position, the thinking goes, the less likely it is that non‐leftist parties will lend him their support, which he needs to obtain congressional majorities. I fear, however, that markets may be getting ahead of themselves. The Colombian congress is minimally ideological and highly transactional. There is still a good chance that, issue by issue, Petro's government can negotiate just enough votes to have his "reforms" approved, in which case only the courts will stand in the way of his agenda. Not that Petro is respectful of any check or balance. This week, he propounded the theory that, since he was elected, his government represents "the will of the people," meaning that any opposition to his political project—including from the news media—is part of an illegitimate, "soft coup." The onslaught, in other words, is far from over. In my view, the worst part about Petro's election victory is that, at this time last year, Colombia was in need of radical reforms. Above all, a chronically sluggish economy required budget discipline, public spending cuts, drastic debt reduction, a strong currency (ideally through dollarization), far lower taxes, labor market deregulation, subsoil privatization, school choice, and an end to non‐tariff barriers. By electing Petro, however, voters decided to do precisely the opposite on all fronts. As warned, most already regret it.
Aerosol particles are a complex component of the atmospheric system which influence climate directly by interacting with solar radiation, and indirectly by contributing to cloud formation. The variety of their sources, as well as the multiple transformations they may undergo during their transport (including wet and dry deposition), result in significant spatial and temporal variability of their properties. Documenting this variability is essential to provide a proper representation of aerosols and cloud condensation nuclei (CCN) in climate models. Using measurements conducted in 2016 or 2017 at 62 ground-based stations around the world, this study provides the most up-to-date picture of the spatial distribution of particle number concentration (Ntot) and number size distribution (PNSD, from 39 sites). A sensitivity study was first performed to assess the impact of data availability on Ntot's annual and seasonal statistics, as well as on the analysis of its diel cycle. Thresholds of 50g% and 60g% were set at the seasonal and annual scale, respectively, for the study of the corresponding statistics, and a slightly higher coverage (75g%) was required to document the diel cycle. Although some observations are common to a majority of sites, the variety of environments characterizing these stations made it possible to highlight contrasting findings, which, among other factors, seem to be significantly related to the level of anthropogenic influence. The concentrations measured at polar sites are the lowest (g1/4g102gcm-3) and show a clear seasonality, which is also visible in the shape of the PNSD, while diel cycles are in general less evident, due notably to the absence of a regular day-night cycle in some seasons. In contrast, the concentrations characteristic of urban environments are the highest (g1/4g103-104gcm-3) and do not show pronounced seasonal variations, whereas diel cycles tend to be very regular over the year at these stations. The remaining sites, including mountain and non-urban continental and coastal stations, do not exhibit as obvious common behaviour as polar and urban sites and display, on average, intermediate Ntot (g1/4g102-103gcm-3). Particle concentrations measured at mountain sites, however, are generally lower compared to nearby lowland sites, and tend to exhibit somewhat more pronounced seasonal variations as a likely result of the strong impact of the atmospheric boundary layer (ABL) influence in connection with the topography of the sites. ABL dynamics also likely contribute to the diel cycle of Ntot observed at these stations. Based on available PNSD measurements, CCN-sized particles (considered here as either >50gnm or >100gnm) can represent from a few percent to almost all of Ntot, corresponding to seasonal medians on the order of g1/4g10 to 1000gcm-3, with seasonal patterns and a hierarchy of the site types broadly similar to those observed for Ntot. Overall, this work illustrates the importance of in situ measurements, in particular for the study of aerosol physical properties, and thus strongly supports the development of a broad global network of near surface observatories to increase and homogenize the spatial coverage of the measurements, and guarantee as well data availability and quality. The results of this study also provide a valuable, freely available and easy to use support for model comparison and validation, with the ultimate goal of contributing to improvement of the representation of aerosol-cloud interactions in models, and, therefore, of the evaluation of the impact of aerosol particles on climate. ; NOAA base funding supports the observatories BRW, BND, MLO, SMO, SPO and THD, where efforts of the dedicated observatory staff and of programmer Derek Hageman are appreciated. BRW observations are also supported in part by the Atmospheric Radiation Measurement (ARM) user facility, a US Department of Energy (DOE) Office of Science user facility managed by the Biological and Environmental Research programme. Measurements at Welgegund are supported by North-West University, the University of Helsinki and the Finnish Meteorological Institute. This publication also forms part of the output of the Biogeochemistry Research Infrastructure Platform (BIOGRIP) of the Department of Science and Innovation of South Africa. Pallas and SMEAR II are grateful for the support of the Academy of Finland Centre of Excellence programme (project no. 272041), the Academy of Finland project Greenhouse gas, aerosol and albedo variations in the changing Arctic (project no. 269095), and the Novel Assessment of Black Carbon in the Eurasian Arctic: From Historical Concentrations and Sources to Future Climate Impacts (NABCEA, project no. 296302). Aerosol measurements at Anmyeon-do were supported by the Korea Meteorological Administration Research and Development Program "Development of Monitoring and Analysis Techniques for Atmospheric Composition in Korea" under grant KMA2018-00522. Measurements at Gosan were supported by the National Research Foundation of Korea (2017R1D1A1B06032548) and the Korea Meteorological Administration Research and Development Program under grant KMI2018-01111. The Lulin station is operated under the grants funded by the Taiwan Environmental Protection Administration. WLG is supported by the China Meteorological Administration, where efforts of the dedicated observatory staff are appreciated. Sites PDM, PUY, GIF, CHC and RUN are partially operated with the support of CNRS-INSU under the long-term observation programme and the French Ministry for Research under the ACTRIS-FR national research infrastructure. PDM and GIF received specific support from the French Ministry of the Environment. ATMO Occitanie is mentioned for sampling operations at PDM. Measurements at SIRTA are hosted by CNRS and by the alternative energies and atomic energy commission (CEA) with additional contributions from the French Ministry of the Environment through its funding to the reference laboratory for air quality monitoring (LCSQA). PUY is grateful for support from ATMO Auvergne Rhône Alpes for sampling operations and the support from the personnel of the Observatoire de Physique du Globe de Clermont-Ferrand (OPGC). The specific support of the Institut de Recherche et Développement (IRD) in France and the Universidad Mayor de San Andrés in Bolivia support operations at CHC operations. The Steamboat Ski Resort provided logistical support and in-kind donations for SPL. The Desert Research Institute is a permittee of the Medicine Bow–Routt National Forests and an equal opportunity service provider and employer. SPL appreciates the extensive assistance of the NOAA/ESRL Federated Aerosol Network, of Ian McCubbin, site manager of SPL, and of Ty Atkins, Joe Messina, Dan Gilchrist and Maria Garcia, who provided technical assistance with the maintenance and data quality control for the aerosol instruments. SGP measurements/mentorship were supported by DOE-7F-30118 and staff on site. The Cape Grim Baseline Air Pollution Monitoring Station is grateful to the Australian Bureau of Meteorology for their long-term and continued support and all the staff from the Bureau of Meteorology and CSIRO, who have contributed to the generation of records reported here. The aerosol measurements at the Jungfraujoch were conducted with financial support from MeteoSwiss (GAW-CH aerosol monitoring programme) and from the European Union as well as the Swiss State Secretariat for Education, Research and Innovation (SERI) for the European Research Infrastructure for the observation of Aerosol, Clouds and Trace Gases (ACTRIS). The International Foundation High Altitude Research Station Jungfraujoch and Gornergrat (HFSJG) is mentioned for providing the research platform at the Jungfraujoch. The aerosol measurements at Kosetice received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no. 654109 and from the project for support of the national research infrastructure ACTRIS – participation of the Czech Republic (ACTRIS-CZ – LM2015037) supported by the Ministry of Education, Youth and Sports of CR within National Sustainability Program I (NPU I), grant agreement no. LO1415. The measurements were also supported by ERDF "ACTRIS-CZ RI" (no. CZ.02.1.01/0.0/0.0/16_013/0001315). Measurements at the Madrid site were funded by the following projects: CRISOL (CGL2017–85344-R MINECO/AEI/FEDER, UE), TIGAS-CM (Madrid Regional Government Y2018/EMT5177), AIRTEC-CM (Madrid Regional Government P2018/EMT4329), REDMAAS2020 (RED2018-102594-T CIENCIA) and Red de Excelencia ACTRIS-ESPAÑA (CGL2017-90884-REDT). Measurements at Montsec and Montseny were supported by the Spanish Ministry of Economy, Industry and Competitiveness and FEDER funds under project HOUSE (CGL2016-78594-R) and by the Generalitat de Catalunya (AGAUR 2017 SGR41 and the DGQA). Aerosol measurements at El Arenosillo Observatory are supported by the National Institute for Aerospace Technology and by different R&D projects of the Ministerio Español de Economía, Industria y Competitividad (MINECO). Aerosol measurements at UGR are supported by the Spanish Ministry of Economy and Competitiveness through projects no. CGL2016-81092-R, CGL2017-90884-REDT, RTI2018-097864-B-I00 and PGC2018-098770-B-I00 and by the Andalusia Regional Government through project no. P18-RT-3820. FKL, HAC and DEM are grateful for funding by project PANhellenic infrastructure for Atmospheric Composition and climate change (MIS 5021516), which is implemented under action Reinforcement of the Research and Innovation Infrastructure, funded by operational programme Competitiveness, Entrepreneurship and Innovation (NSRF 2014-2020) and co-financed by Greece and the European Union (European Regional Development Fund). CPC measurements at Sonnblick are supported by the Climate and Air Quality Commission of the Austrian Academy of Sciences and the office of the provincial government Salzburg, Unit 5/02. At CMN, aerosol measurements were partially supported by the Italian Ministry of Research and Education. Measurements at Birkenes II are financed by the Norwegian Environment Agency. VAV is grateful for various Swedish FORMAS, Swedish Research Council (VR) grants and the Magnus Bergvall and Märta och Erik Holmberg foundations and the Swedish EPA for making the research possible at the VAV site. NMY wishes to thank the many technicians and scientists of the Neumayer overwintering crews, whose outstanding commitment enabled continuous, high-quality aerosol records over many years. Gunter Löschau is acknowledged for his contribution to the data acquisition at ANB, DTC and DRN. Financial support This research was supported by the European Commission's Horizon 2020 Framework Programme (ACTRIS2 (grant agreement no. 654109)), the University of Helsinki, the Finnish Meteorological Institute, the Department of Science and Innovation of South Africa, the Academy of Finland Centre of Excellence programme (project no. 272041), the Academy of Finland project Greenhouse gas, aerosol and albedo variations in the changing Arctic (project no. 269095), the Novel Assessment of Black Carbon in the Eurasian Arctic: From Historical Concentrations and Sources to Future Climate Impacts (NABCEA, project no. 296302), the Korea Meteorological Administration Research and Development Program "Development of Monitoring and Analysis Techniques for Atmospheric Composition in Korea" (grant no. KMA2018-00522), the National Research Foundation of Korea (grant no. 2017R1D1A1B06032548), the Korea Meteorological Administration Research and Development Program (grant no. KMI2018-01111), the Taiwan Environmental Protection Administration, the China Meteorological Administration, the National Scientific Foundation of China (41675129, 41875147), the National Key R&D Program of the Ministry of Science and Technology of the People's Republic of China (grant no. 2016YFC0203305 and 2018YFC0213204), the Chinese Academy of Meteorological Sciences (2020KJ001), the Innovation Team for Haze-fog Observation and Forecasts of MOST and CMA, CNRS-INSU, the French Ministry for Research under the ACTRIS-FR national research infrastructure, the French Ministry of the Environment, MeteoSwiss (GAW-CH aerosol monitoring programme), the Swiss State Secretariat for Education, Research and Innovation (SERI), the Ministry of Education, Youth and Sports of CR within National Sustainability Program I (NPU I, grant no. LO1415), ERDF "ACTRISCZ RI" (grant no. CZ.02.1.01/0.0/0.0/16_013/0001315), CRISOL (CGL2017-85344-R MINECO/AEI/FEDER, UE), TIGAS-CM (Madrid Regional Government Y2018/EMT-5177), AIRTEC-CM (Madrid Regional Government P2018/EMT4329), REDMAAS2020 (RED2018-102594-T CIENCIA), Red de Excelencia ACTRIS-ESPAÑA (CGL2017-90884-REDT), the Spanish Ministry of Economy, Industry and Competitiveness, FEDER funds (project HOUSE, grant no. CGL2016-78594-R), the Generalitat de Catalunya (AGAUR 2017 SGR41 and the DGQA), the National Institute for Aerospace Technology, the Ministerio Español de Economía, Industria y Competitividad (MINECO), the Spanish Ministry of Economy and Competitiveness (projects no. CGL2016-81092-R, CGL2017-90884-REDT, RTI2018-097864-B-I00 and PGC2018-098770-B-I00), the Andalusia Regional Government (project no. P18-RT-3820), the PANhellenic infrastructure for Atmospheric Composition and climate change (MIS 5021516), Research and Innovation Infrastructure, Competitiveness, Entrepreneurship and Innovation (grant no. NSRF 2014-2020), the Italian Ministry of Research and Education, the Norwegian Environment Agency, Swedish FORMAS, the Swedish Research Council (VR), the Magnus Bergvall foundation, the Märta och Erik Holmberg foundation, and the Swedish EPA. ; Peer reviewed
Este artículo se propone analizar las estrategias de seguridad alimentaria y nutricional (SAN) desarrollada por los miembros de la Asociación de Orgánicos Productores de Ceará Mirim (APPOCM), ubicado en el estado de Rio Grande do Norte. La misma fue creada en el año 2010, con el desafío de producir alimentos de calidad en cantidad suficiente, sin perjudicar el medio ambiente y teniendo en cuenta las relaciones de equidad social. Es una de las escasas iniciativas de este tipo que tienen lugar en un territorio marcado por los peores indicadores sociales en Brasil (un Índice de Desarrollo Humano, IDH = 0,555). La investigación es del tipo cualitativo y los datos analizados se obtuvieron a través de entrevistas semiestructuradas, realizadas en los sitios de producción de cada agricultor. Tomando como referencia el concepto de SAN, la herramienta de investigación trató de identificar y caracterizar las estrategias de SAN a través de las siguientes variables: cómo acceder a los alimentos; las formas de adquisición de los alimentos; estrategias para el autoconsumo; políticas públicas accesibles y sus consecuencias, incluyendo la manera cómo se asocian con la cultura alimentaria local. Del estudio se concluyó que la mayoría de las estrategias de SAN identificadas han resultado del encadenamiento de diferentes políticas públicas. Estas estrategias han traído mejoras en la alimentación, provocando así mismo cambios en los hábitos alimentarios en el área objeto de estudio –en particular, en la diversificación de la producción destinada al autoconsumo–. Esto a su vez ha garantizado autonomía alimentaria, al tiempo que ha ampliado los canales de comercialización, ya sea a través de ferias o de los mercados institucionales. También se encontró que se ampliaron las relaciones de reciprocidad (i.e., los actos de dar, recibir e intercambiar). Tales relaciones son indispensables para alcanzar la seguridad alimentaria en tiempos de dificultades, además de contribuir a promover la producción orgánica, mediante los intercambios de insumos. ; This article analyzes the strategies of food and nutritional security (SAN) developed by the members of the Association of Organic producers of Ceara Mirim (APPOCM), located in the State of Rio Grande do Norte, created in the year of 2010, with the challenge of producing food quality in sufficient quantity, without harming the environment and considering the relations of social equity. One of the few initiatives of this kind in a territory marked by the worst social indicators in Brazil (HDI = 0.555). The data reviewed here were obtained from semi-structured interviews, carried out in the places of production of each farmer and departing from a qualitative approach. Taking as reference the concept of SAN, the instrument of research, sought to identify and characterize the strategies from the following variables: How does access to food; the form of purchasing food; strategies for consumption; public policies accessed that have strengthened those strategies and as it joins the local food culture. From the study, it was concluded that most SAN strategies identified resulted from the chaining of different public policies that strengthened existing and developed other strategies, as in the case of organic production that constitutes the primary motivation, including for the Organization of the Group researched. These strategies have brought improvements in feed, causing changes in your eating habits, in particular, on the diversification of production to consumption. This in turn, has secured greater autonomy power and expanded sales channels, either through fairs or institutional markets. It was found, also,that relations of reciprocity (acts of giving, exchange and receive) widened after the organic production and that these are indispensable in ensuring food in times of difficulties, in addition to contributing to promote organic production, through the exchanges of inputs. ; Cet article vise à analyser les stratégies de sécurité alimentaire et nutritionnelle (SAN) développées par les membres de l'Association de Producteurs Bio de Ceará Mirim (APPOCM), dans l'État de Rio Grande do Norte. Cette association a été créée en 2010, dans le but de produire des aliments de qualité, respectant l'environnement et en prenant en compte l'équité sociale. Cette initiative est l'une des rares qui a été mise en place au Brésil, dans un territoire qui connait les pires indicateurs sociaux (HDI = 0,555). Cette recherche est réalisée sous une approche qualitative et les données proviennent d'entrevues semi-structurées. En prenant comme référence le concept de SAN, on a cherché à identifier, caractériser et analyser les aspects suivants : Comment l'agriculteur accède-t-il à l'alimentation (achète-t-il ses aliments ou bien il les produit); quel est le formulaire d'achat d'aliments; quelles sont les stratégies pour la consommation; quelles sont les politiques publiques qui ont été utilisées pour renforcer ces stratégies et si elles sont reliées à la culture alimentaire locale. La recherche a conclu que la plupart des stratégies de SAN identifiées résultent des politiques publiques successives, ce qui a renforcé et développé d'autres stratégies. C'est le cas du mode de production biologique qui constitue la principale motivation de l'organisation du groupe étudié. Ces stratégies ont apporté des améliorations dans l'alimentation des agriculteurs provoquant des changements dans les habitudes alimentaires, en particulier, en ce qui concerne la diversification de la production et de la consommation. De même, les agriculteurs ont obtenu une plus grande autonomie et ont élargi leurs canaux de vente grâce aux marchés qui sont mis en place pour l État. On a constaté, aussi que les relations de réciprocité (donation et échange) se sont trouvées renforcées après la mise en place du mode de production biologique et que ces relations sont indispensables afin d'assurer l'approvisionnement en aliments pendant les périodes de difficulté et de contribuer à encourager la production biologique à travers les échanges de semences et d'autres formes de coopération. ; Este artigo se propõe a analisar as estratégias de Segurança Alimentar e Nutricional (SAN) desenvolvidas pelos membros da Associação de Produtores e Produtoras Orgânicos de Ceará Mirim (APPOCM), localizada no estado do Rio Grande do Norte. Essa instituição foi criada em 2010, com o desafio de produzir alimentos com qualidade e quantidade suficiente, respeitando o meio ambiente e o princípio de equidade social. Essa associação é uma das poucas iniciativas dessa natureza em um território que apresenta os mais baixos indicadores sociais do Brasil (IDH = 0,555). A pesquisa é de natureza qualitativa e os dados aqui analisados foram obtidos a partir de entrevistas semiestruturadas. O trabalho buscou identificar, caracterizar e analisar as estratégias de Segurança Alimentar e Nutricional partir das seguintes variáveis: como se dá o acesso ao alimento; as formas de aquisição de alimentos; estratégias para autoconsumo; políticas públicas acessadas e seus desdobramentos, incluindo como isso se associa à cultura alimentar local. A partir do estudo, concluiu-se que a maior parte das estratégias de SAN identificadas resulta do encadeamento com diferentes políticas públicas. Estas iniciativas acabaram por ativar outras medidas, como no caso da produção orgânica empreendida pelos agricultores da associação. Tais estratégias trouxeram melhorias na alimentação, trazendo mudanças positivas nos hábitos alimentares, em especial, na diversificação da produção de autoconsumo. Isto por sua vez, tem garantido maior autonomia alimentar e ampliado os canais de comercialização, seja por meio de feiras, seja através do acesso aos mercados institucionais. Verificou-se, também, que as relações de reciprocidade (atos de doar, trocar e receber) se ampliaram, as quais são imprescindíveis para a garantia de alimentos em momentos de dificuldades, além de contribuir para fomentar a produção orgânica, através das trocas de insumos. ; 151-164
"Sacred Foundations argues that the medieval church was a fundamental force in European state formation. Existing accounts focus on early modern warfare or contracts between the rulers and the ruled. In contrast, this major study shows that the Catholic Church both competed with medieval monarchs and provided critical templates for governing institutions, the rule of law, and parliaments. The Catholic Church was the most powerful, wealthiest, and best-organized political actor in the Middle Ages. Starting in the eleventh century, the papacy fought for the autonomy of the church, challenging European rulers and then claiming authority over people, territory, and monarchs alike. Anna Grzymała-Busse demonstrates how the church shaped distinct aspects of the European state. Conflicts with the papacy fragmented territorial authority in Europe for centuries to come, propagating urban autonomy and ideas of sovereignty. Thanks to its organizational advantages and human capital, the church also developed the institutional precedents adopted by rulers across Europe-from chanceries and taxation to courts and councils. Church innovations made possible both the rule of law and parliamentary representation. Bringing to light a wealth of historical evidence about papal conflict, excommunications, and ecclesiastical institutions, Sacred Foundations reveals how the challenge and example of powerful religious authorities gave rise to secular state institutions and galvanized state capacity"--
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Penelitian ini bertujuan untuk mengetahui pengaruh beauty vlogger dan celebgram endorser pada brand image dan dampaknya terhadap purchase intention pada produk Make Over. Tipe penelitian ini menggunakan pendekatan explanatory research dengan pendekatan kuantitatif. Dengan metode pengumpulan data menggunakan kuesioner dengan sampel sebesar 100 responden yang disebar secara online dengan menggunakan metode path analysis. Berdasarkan hasil analisis data disimpulkan bahwa beauty vlogger berpengaruh signifikan pada brand image dan purchase intention, celebgram endorser berpengaruh signifikan pada brand image, celebgram endorser tidak berpengaruh secara signifikan pada purchase intention dan brand image berpengaruh signifikan sebagai variabel mediasi antara beauty vlogger dan purchase intention.Kata Kunci: Beauty Vlogger, Celebgram Endorser, Brand Image, Purchase Intention dan Make Over. DAFTAR PUSTAKA Abdullah, T. & Tantri, F. 2012. Manajemen Pemasaran. Jakarta: PT. Raja Grafindo Persada. Aditya, Kadek Yoga & I Made Wardana. 2017. Peran Brand Equity Dalam Memediasi Pengaruh Word Of Mouth Terhadap Purchase intention. E-Jurnal Manajemen Unud, 6 (2), hal.830-856. Alma, Buchari. 2013. Manajemen Pemasaran dan Pemasaran Jasa. Bandung: Alfabeta. Aisyah, Siti. 2017. Video Blog sebagai Media Representasi Diri Vlogger di Kota Makassar. Departemen Ilmu Komunikasi Fakultas Ilmu Sosial dan Ilmu Politik (Skripsi dipublikasikan) Universitas Hasanuddin Makassar. Arikunto, S. 2013. Prosedur Penelitian: Suatu Pendekatan Praktik. Jakarta: Rineka Cipta. Arora, Lokesh & Sharma, Bhuvanesh Kumar. 2018. Influence of Review Quality, Review Quantity and Review Credibility on Purchase Intention in the context of High Involvement Product. European Journal of Applied Business Management, Special Issue, 4(4), pp 25-40. Assael, Henry. 2001. Consumer Behavior 6th Edition. New York: Thomson-Learning. Bramantya, Yan Bayu & Jatra, Made. 2016. Pengaruh Celebrity Endorser dan Brand Image Terhadap Keputusan Pembelian Yamaha Jupiter MX di Kota Denpasar. E-Jurnal Manajemen Unud, Vol 5 No. 3. BPOM. 2019. Peraturan Badan POM RI Nomor 23 Tahun 2019 Mengenai Persyaratan Teknis Bahan Kosmetika. Diakses 18 Januari 2021 pada pukul 03:20 WIB https://notifkos.pom.go.id Busler. 2000. The Match-Up Hypothesis: Physical Attractiveness, Expertise and The Role of Fit On Brand Attitude, Purchase Intention and Brand Belief. Journal of Advertising. Vol. 29 Chakraborty, Uttam. 2019. The impact of Source Credible Online Reviews on Purchase Intention: The Mediating Roles of Brand Equity Dimensions. Journal of Research in Interactive Marketing, diakses pada tanggal 18 Mei 2019 pukul 00:02 WIB. https:// doi.org/10.1108/JRIM-06-2018-0080 Chen, Jui-Lung & Dermawan, Apritika. 2020. The Influence of YouTube Beauty Vloggers on Indonesian Consumers' Purchase Intention of Local Cosmetic Products. International Journal of Business and Management; Vol. 15, No. 5 Choi, G.Y. & Behm-Morawitz, E. 2017. Giving a new makeover to STEAM: Establishing youtube beauty gurus as digital literacy educators through messagges and effects on viewers, Computers ini Human Behavior, 73 : 80-91. CNBC Indonesia. 2020. Ekspor Tembus Rp4,4 T, Indusstri Kosmetik & Farmasi RI Cuan. Diakses pada tanggal 18 Januari 2021 pada pukul 23:54 WIB.https://www.cnbcindonesia.com/news/20200803095618-4-177010/ekspor-tembus-rp-44-t-industri-kosmetik-farmasi-ri-cuan Dewi, I.D & Ardani I.G.A.K.S. 2018. Peran Brand Image Memediasi Pengaruh Word Of Mouth Terhadap Purchase Intention(Studi Pada Produk Mie Samyang Hot Spicy Chicken di Kota Denpasar). E-Jurnal Manajemen Unud, Vol. 7, No. 4, 2018: 1771-1801. Djafarova, E., & Rushworth, C. 2017. Exploring the credibility of online celebrities' Instagram profiles in influencing the purchase decisions of young female users. Computers in Human Behavior, 68, 1-7. Durianto, Darmadi . 2013. Strategi Menaklukan Pasar Melalui Riset Ekuitas dan Perilaku Merek (cet. ke-10). Jakarta: PT Gramedia Pustaka Utama. Engel et al,. 2002. Perilaku konsumen. Alih bahasa Drs. F.X. Budiyanto. Jakarta: Binarupa Aksara. Ghozali, Imam. 2016. Structural Equation Modeling, Metode Alternatif dengan Partial Least Square (PLS). Edisi 4. Semarang : Badan Penerbit Universitas Diponegoro. Hardjanti, A., & Siswanto, H. 2014. Pengaruh dimensi endorser credibility dan brand credibility terhadap dimensi concumer-based brand equity. Jurnal iImiah Widya, 2(3), 42–50. Hassan, S., & Jamil, R. (2014). Influence of Celebrity Endorsement on Consumer Purchase Intention for Existing Products: A Comparative Study. Journal of Management Info, 4(1), 1-23.Hootsuite-we are social. 2019. Digital 2019: Global Internet Use Accelerates. Diakses pada tanggal 20 Mei 2019 pukul 03:34 WIB. https://wearesocial.com/blog/2019/01/digital-2019-global-internet-use-accelerates. Hsu, C. L., Chuan-Chuan Lin, J., & Chiang, H. S. 2013. The Effects of Blogger Recommendations on Customers online shopping intentions. Internet Research, 23 (1), pp: 69-88. Huang, Shiu Li & Ku, Hsiou Hsuan. 2016. Brand Image Management for Nonprofit Organizations: Exploring The Relationships Between Websites, Brand Images and Donations. Journal of Electronic Commerce Research, Vol 17 no 1. Hui, Tee Xue. 2017. The Effect of Source Credibility on Consumers' Purchase Intention in Malaysia Online Community. Journal of Arts & Social Sciences Vol 1, Issue 1, 12‐20. Hutapea. 2016. Pengaruh Beauty Vlogger dan Brand Image: Survei Pengaruh Beauty Vlogger Sebagai Endorser Terhadap Brand Image The Body shop. Departemen Ilmu Komunikasi Fakultas Ilmu Sosial dan Politik (Skripsi dipublikasikan) Universitas Gadjah Mada,Yogyakarta Instagram. 2020. Make Over. Diakses pada 3 Januari 2020 pukul 04:31 WIB. https://www.instagram.com/p/B60NjKSHy9r/ Jalilvand, Mohammad Reza & Samiei, Neda .2012. "The effect of electronic word of mouth on brand image and purchase intention: An empirical study in the automobile industry in Iran", Marketing Intelligence & Planning, Vol. 30 Issue: 4, pp.460-476 Jung, Eun Lee & Watkins, Brandi. 2016. Youtube vloggers' influence on consumer luxury brand perceptions and intentions Journal of Business Research 69 5753–5760. Kotler, Philip & Gerry Armstrong. 2014. Principle Of Marketing, 15th edition. New Jersey: Pearson Pretice Hall. Kotler, Philip & Kevin Lane Keller. 2016. Marketing Management, 15th Edition New Jersey: Pearson Pretice Hall, Inc. Mariezka, Filza Intan et al., (2018). Pemaknaan Profesi Beauty Vlogger Melalui Pengalaman Komunikasi. NYIMAK Journal of Communication Vol 2 No. 2 Media, L. 2009. Youtube & Google Video; Membuat Mengedit dan Upload Video. Yogyakarta: Penerbit MediaKom. Metha. 1994. Prinsip-prinsip Pemasaran. Jakarta: Erlangga. 12 Mazzini Muda et al. / Procedia - Social and Behavioral Sciences 130 ( 2014 ) 11 – 2012 Mazzini Muda et al. / Procedia - Social and Behavioral Sciences 130 ( 2014 ) 11 – 20Muda, Mazzini, et al. 2014. Celebrity Entrepreneur Endorsement and Advertising Effectiveness. Procedia - Social and Behavioral Sciences 130 11 – 20 Muham, Shara Natisa. 2019. Penggunaan Celebgram (Celebrity Endorser Instagram) dalam Promosi Produk MD Clinic by MS Glowing Skin. Jurnal Desain vol. 6 no, 3. Nazir, Moh. 2013. Metode Penelitian. Bogor: Ghalia Indonesia. Nugroho, Adi Rifqi. 2013. Analisis Faktor-Faktor yang Mempengaruhi Keputusan Pembelian Dengan Sistem Pre Order Secara Online (Studi Kasus Pada Online Shop Chopper Jersey). Semarang: Fakultas Ekonomika dan Bisnis Universitas Diponegoro. Nugraha, Anas & Setyanto, Refius Pradipta. 2018. The Effects of Vlogger Credibility as Marketing Media on Brand Awareness to Customer Purchase Intention. Journal of Research in Management Vol. 1 No. 2, 2018, pp 1-10 Ohanian, R. 1990. Construction and validation of a scale to measure celebrity endorsers' perceived expertise, trustworthiness, and attractiveness. Journal of advertising, 19(3), 39-52. Orlando, Dillon. 2015. Analisa Pengaruh Brand Image dan Brand Awareness Terhadap Purchase Intention Sepeda Motor "Kawasaki Ninja 250 Fi". Jurnal Manajemen Pemasaran Petra. Vol. 3 No. 1 1-9. Pixability Company. 2014. Beauty on Youtube: How Youbube is radically transforming the beauty industry and what that means for brand. Diakses pada tanggal 18 Januari 2021 pukul 02:34 WIB https://www.pixability.com Putri, Maharani Nindiya & Listiani, Endri. 2018. Electronic Word of Mouth (E-WOM) is Used by Beauty Vloggers and Its Effect on Purchase Intention. Journal of Management Communication Volume 4, No. 2. Pornpitakpan, C. 2003. Validation of the celebrity endorsers' credibility scale: Evidence from Asians. Journal of Marketing Management, 19(1-2), 179-195. Rachmadi, K.R & Nurhajati. 2018. Pengaruh Vlogger Review Sebagai Celebrity Endorser Terhadap Purchase Intention dengan Brand Image Sebagai Intervening Variabel pada Produk Kosmetik dan Perawatan Wajah. JIMMU. Volume III- Nomor 1. Rahmi, Y, & Sekarsih, L. 2017. The Influence of Beauty Vlog on Perceived Source Credibility and Purchase Intention. Makara Hubs-Asia, 21(1): 13-23. Rashid, M.A, Zabid. A., Nallamuthu, Jainthy & Sidin, Samsinar. 2002. Perceptionss of Advertising and Celebrity Endorsement in Malaysia. Asia Pacific Management Review.7(4),53-554. Ruhamak, M.Dian & Rahayu, Budi. 2016. Pengaruh Word Of Mouth Terhadap Purchase Intention melalui Brand Image pada Lembaga Kursus Bahasa Inggris Dynamic English Course Pare. Jurnal Ekonomi Universitas Kadiri. Vol. 1, No. 2, 188 – 204 Sabdosih, Zakiya. 2013. Pengaruh Variabel Celebrity Endorser terhadap Citra Merek L'oreal (Studi Produk L'oreal Paris Total Repair di Fakultas Ekonomi dan Bisnis Universitas Brawijaya Malang. Jurnal Ilmiah Mahasiswa FEB Vol 1, No.2 Schiffman, Leon & Kanuk, Leslie Lazar. 2010. Perilaku Konsumen. Jakarta: PT Indeks. Sekaran, Umar 2006. Metodologi Penelitian untuk Bisnis, Edisi 4, Buku 1, Jakarta: Salemba Empat.Setiadi, Nugroho J. 2013. Perilaku Konsumen Perspektif Kontemporer pada Motif, Tujuan, dan Keinginan Konsumen. Jakarta: PT. Kharisma Putra Utama. Shimp, Terence A., 2002. Periklanan promosi : aspek tambahan komunikasi pemasaran terpadu; Jilid I. Jakarta: Erlangga.Singh, Ramendra Pratap & Banerjee, Neelotpaul. 2018. Exploring the Influence of Celebrity Credibility on Brand Attitude, Advertisement Attitude and Purchase Intention. Global Business Review Vol. 19(6) 1622–1639. Sinaga, R.E.M & Kusumawati, A. 2018. Pengaruh Youtube Beauty Vlogger Terhadap Minat Beli Konsumen dan Dampaknya Terhadap Keputusan Pembelian Produk (Studi pada Pengguna Kosmetik Maybelline di Indonesia). Jurnal Administratsi Bisnis (JAB). Vol. 63 No. 1Solimun., Fernandes, A. A. R., Nurjannah. 2017. Metode Statistika Multivariat: Pemodelan Persamaan Struktural (SEM). Malang: UB Press. Stefani, Selfi. 2013. Analisis Pengaruh Iklan Televisi, Celebrity Endorser, Kualitas Produk dan Citra Merek terhadap Keputusan Pembelian pada Produk Kosmetik Berlabel Halal Wardah. Skripsi Fakultas Ekonomi dan Bisnis Universitas Islam Negeri Syarif Hidayatullah. Sugiyono. 2016. Metode Penelitian Kuantitatif Kualitataif dan Kombinasi (Mixed Methods).Bandung: Alfabeta. Sujana, Made Shinta Ayu Saraswati & Giantari, I Gusti Ayu Ketut. 2017. Peran Brand Image Memediasi Celebrity Endorser dengan Purchase Intention. Forum Keuangan dan Bisnis Indonesia (FKBI), Vol. 6 Sujarweni, V. Wiratna. 2014. Metode Penelitian: Lengkap, Praktis, dan Mudah Dipahami. Yogyakarta: Pustaka Baru Press Sunarti, Wibowo, Edi & Utami, Setyaningsih Sri. 2019. Pengaruh Beauty Vlogger Terhadap Minat Beli Produk Kosmetik Wardah dengan Citra Merek sebagai Variabel Mediasi (Survei pada Mahasiswa Universitas Slamet Riyadi Surakarta). Jurnal Ekonomi dan Kewiraushaan Vol. 19 No. 4. Swa.co.id. 2018. Make Over Perkuat Diri sebagai Brand Make up Profesional. Diakses pada tanggal 10 Januari 2021 pukul 01:44 WIBhttps://swa.co.id/swa/business-strategy/make-over-perkuat-diri-sebagai-brand-make-up-profesionalSyahdiany, G., Hanifa, F. H. 2016. Pengaruh citra merek dan harga terhadap keputusan pembelian Ramen X Kota Bandung tahun 2016. Prosiding SnaPP2016 Sosial, Ekonomi, dan Humaniora, 6 (1). 94-101. Thusyanthy, Vadivelu & Tharanikaran, Vadivelu. 2015. The Relationship Variables to Celebrity Endorsement and Brand Equity A Comprehensive Review. Journal of Business and Management, 10 (11): pp: 212-221 Tirto.id. 2018. "Saling Menguntungkan antara Beauty Vlogger dan Industri Kecantikan". Diakses pada tanggal 21 Mei 2019 pada pukul 14:27 WIB https://tirto.id/saling-menguntungkan-antara-beauty-vlogger-dan-industri-kecantikan-c2aa. Tjiptono, F. 2016. Pemasaran: Esensi dan Aplikasi. Yogyakarta: Andi. Widodo, W.D.P.S & Mawardi, M. Kholid 2017. Pengaruh Beauty Vlogger Terhadap Source Characteristics serta Dampaknya Terhadap Purchase Intention. Jurnal Bisnis (JAB). Vol. 47 No. 1 Juni 2017. Wiyono, Budi. 2009. Pengaruh Word of Mouth dalam Keputusan Pembelian. Bandung: Kappa Sigma. Yamin, Sofyan & Kurniawan, Heri. 2009. Structural Equation Modeling. Jakarta: Salemba Empat. Youtube.com, 2019. "TASYA FARASYA'S BEAUTY AWARDS 2019". Diakses pada tanggal 15 Januari 2020 pukul 02:45 WIB https://www.youtube.com/watch?v=hvuDvjcP-JI
A locus at 19p13 is associated with breast cancer (BC) and ovarian cancer (OC) risk. Here we analyse 438 SNPs in this region in 46,451 BC and 15,438 OC cases, 15,252 BRCA1 mutation carriers and 73,444 controls and identify 13 candidate causal SNPs associated with serous OC (P=9.2 × 10(-20)), ER-negative BC (P=1.1 × 10(-13)), BRCA1-associated BC (P=7.7 × 10(-16)) and triple negative BC (P-diff=2 × 10(-5)). Genotype-gene expression associations are identified for candidate target genes ANKLE1 (P=2 × 10(-3)) and ABHD8 (P<2 × 10(-3)). Chromosome conformation capture identifies interactions between four candidate SNPs and ABHD8, and luciferase assays indicate six risk alleles increased transactivation of the ADHD8 promoter. Targeted deletion of a region containing risk SNP rs56069439 in a putative enhancer induces ANKLE1 downregulation; and mRNA stability assays indicate functional effects for an ANKLE1 3'-UTR SNP. Altogether, these data suggest that multiple SNPs at 19p13 regulate ABHD8 and perhaps ANKLE1 expression, and indicate common mechanisms underlying breast and ovarian cancer risk. ; We thank all the individuals who took part in these studies and all the researchers, clin- icians, technicians and administrative staff who have enabled this work to be carried out, in particular those involved in the COGS project: Rosalind A. Eeles, Ali Amin Al Olama, Zsofia Kote-Jarai, Sara Benlloch (PRACTICAL), Andrew Lee, and Ed Dicks, Craig Luccarini and the staff of the Centre for Genetic Epidemiology Laboratory, the staff of the CNIO genotyping unit, Daniel C. Tessier, Francois Bacot, Daniel Vincent, Sylvie LaBoissie ` re and Frederic Robidoux and the staff of the McGill University and Ge ́ nome Que ́ bec Innovation Centre, Sune F. Nielsen, Borge G. Nordestgaard, and the staff of the Copenhagen DNA laboratory, and Julie M. Cunningham, Sharon A. Windebank, Christopher A. Hilker, Jeffrey Meyer and the staff of Mayo Clinic Genotyping Core Facility. BCAC (acknowledgements by study) (ABCFS) : Maggie Angelakos, Judi Maskiell, Gillian Dite. (ABCS) C Ellen van der Schoot, Sanquin Amsterdam. (ACP) The ACP study wishes to thank the participants in the Thai Breast Cancer study. Special Thanks also go to the Thai Ministry of Public Health (MOPH), doctors and nurses who helped with the data collection process. Finally, the study would like to thank Dr Prat Boonyawongviroj, the former Permanent Secretary of MOPH and Dr Pornthep Siriwanarungsan, the Department Director-Generalof Disease Control who have supported the study throughout. (BBCS) Eileen Williams, Elaine Ryder-Mills, Kara Sargus (BIGGS) Niall McInerney, Gabrielle Colleran, Andrew Rowan, Angela Jones. (BSUCH) Peter Bugert, Medical Faculty Mannheim (CGPS) Staff and participants of the Copenhagen General Population Study. For the excellent technical assistance: Dorthe Uldall Andersen, Maria Birna Arnadottir, Anne Bank, Dorthe Kjeldgård Hansen (CNIO-BCS) Guillermo Pita, Charo Alonso, Daniel Herrero, Nuria A ́ lvarez, Pilar Zamora, Primitiva Menendez, the Human Genotyping-CEGEN Unit (CNIO)(CTS). The CTS Steering Committee includes Leslie Bernstein, Susan Neuhausen, James Lacey, Sophia Wang, Huiyan Ma, Yani Lu, and Jessica Clague DeHart at the Beckman Research Institute of City of Hope, Dennis Deapen, Rich Pinder, Eunjung Lee, and Fred Schumacher at the University of Southern California, Pam Horn-Ross, Peggy Reynolds, Christina Clarke Dur and David Nelson at the Cancer Prevention Institute of California, and Hoda Anton-Culver, Argyrios Ziogas, and Hannah Park at the University of California Irvine. (ESTHER) Hartwig Ziegler, Sonja Wolf, Volker Hermann. (GC-HBOC) Heide Hellebrand, Stefanie Engert and GC-HBOC (Supported by Deutsche Krebshilfe). (GENICA) The GENICA Network: Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, and University of Tu ̈bingen, Germany [HB, Wing-Yee Lo, Christina Justenhoven], German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) [HB], Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany [Yon-Dschun Ko, Christian Baisch], Institute of Pathology, University of Bonn, Germany [Hans-Peter Fischer], Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany [UH], Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany [Thomas Bru ̈ning, Beate Pesch, Sylvia Rabstein, Anne Lotz]; and Institute of Occupational Medicine and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Germany [Volker Harth] (HEBCS) Kirsimari Aaltonen, Karl von Smitten, Sofia Khan, Tuomas Heikkinen, Irja Erkkila ̈ . (HMBCS) Natalia Antonenkova, Peter Hillemanns, Hans Christiansen and Johann H. Karstens (KBCP) Eija Myo ̈ ha ̈ nen, Helena Kemila ̈ inen. (kConFab/AOCS) We wish to thank Heather Thorne, Eveline Niedermayr, all the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics, and the Clinical Follow Up Study (which has received funding from the NHMRC, the National Breast Cancer Foundation, Cancer Australia, and the National Institute of Health (USA)) for their contributions to this resource, and the many families who contribute to kConFab. (LAABC) We thank all the study participants and the entire data collection team, especially Annie Fung and June Yashiki. (LMBC) Gilian Peuteman, Dominiek Smeets, Thomas Van Brussel and Kathleen Corthouts. (MARIE) Petra Seibold, Judith Heinz, Nadia Obi, Alina Vrieling, Sabine Behrens, Ursula Eilber, Muhabbet Celik, Til Olchers and Stefan Nickels. (MCCS) MCCS cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further supported by Australian NHMRC grants 209057, 251553 and 504711 and by infrastructure provided by Cancer Council Victoria. Cases and their vital status were ascertained through the Victorian Cancer Registry (VCR) and the Australian Institute of Health and Welfare (AIHW), including the National Death Index. (MBCSG) Bernard Peissel and Daniela Zaffaroni and Giulietta Scuvera of the Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy; Monica Barile and Irene Feroce of the Istituto Europeo di Oncologia (IEO), Milan, Italy; and the personnel of the Cogentech Cancer Genetic Test Laboratory. (MTLGEBCS) We would like to thank Martine Tranchant (CHU de Que ́ bec Research Center), Marie-France Valois, Annie Turgeon and Lea Heguy (McGill University Health Center, Royal Victoria Hospital; McGill Uni- versity) for DNA extraction, sample management and skilful technical assistance. J.S. is Chairholder of the Canada Research Chair in Oncogenetics. (MYBRCA) Phuah Sze Yee, Peter Kang, Kang In Nee, Kavitta Sivanandan, Shivaani Mariapun, Yoon Sook-Yee, Daphne Lee, Teh Yew Ching and Nur Aishah Mohd Taib for DNA Extraction and patient recruitment. (NBHS) We thank study partcipants and research staff for their contributions and commitment to this study. (OBCS) Meeri Otsukka, Kari Mono- nen(OFBCR) Teresa Selander, Nayana Weerasooriya(ORIGO) We thank E. Krol-War- merdam, and J. Blom for patient accrual, administering questionnaires, and managing clinical information. The LUMC survival data were retrieved from the Leiden hospital- based cancer registry system (ONCDOC) with the help of Dr J. Molenaar. (PBCS) Louise Brinton, Mark Sherman, Neonila Szeszenia-Dabrowska, Beata Peplonska, Witold Zatonski, Pei Chao, Michael Stagner(pKARMA) The Swedish Medical Research Counsel. (RBCS) Petra Bos, Jannet Blom, Ellen Crepin, Elisabeth Huijskens, Annette Heemskerk, the Erasmus MC Family Cancer Clinic. (SASBAC) The Swedish Medical Research Counsel. (SBCGS) We thank study partcipants and research staff for their contributions and commitment to this study. (SBCS) Sue Higham, Helen Cramp, Ian Brock, Malcolm W. R. Reed, Sabapathy Balasubramanian and Dan Connley. (SEARCH) The SEARCH and EPIC teams. (SGBCC) We thank the participants and research coordinator Kimberley Chua. (SKKDKFZS) We thank all study participants, clinicians, family doctors, researchers and technicians for their contributions and commitment to this study. (TNBCC) Robert Pilarski and Charles Shapiro were instrumental in the formation of the OSU Breast Cancer Tissue Bank. We thank the Human Genetics Sample Bank for processing of samples and providing OSU Columbus area control samples. (UKBGS) We thank Breakthrough Breast Cancer and the Institute of Cancer Research for support and funding of the Breakthrough Generations Study, and the study participants, study staff, and the doctors, nurses and other health care providers and health information sources who have contributed to the study. We acknowledge NHS funding to the Royal Marsden/ ICR NIHR Biomedical Research Centre. OCAC (acknowledgements by study) : This study would not have been possible without the contributions of the following: J Dennis, P. Hall (COGS); D. C. Tessier, F. Bacot, D. Vincent, S. LaBoissie ` re and F. Robidoux and the staff of the genotyping unit, (Genome Quebec); D. C. Whiteman, P. M. Webb, A. C. Green, N. K. Hayward, P. G. Parsons, D. M. Purdie, B. M. Smithers, D. Gotley, A. Clouston, I. Brown, S. Moore. K. Harrap, T. Sadkowski, S. O'Brien, E. Minehan, D. Roffe, S. O'Keefe, S. Lipshut, G. Connor . Berry, F. Walker, T. Barnes, J. Thomas, L. Terry, M. Connard, L. Bowes, M-R. Malt, J. White, C. Mosse, N. Tait, C. Bambach, A. Biankan, R. Brancatisano, M. Coleman, M. Cox, S. Deane, G. L. Falk, J. Gallagher, M. Hollands, T. Hugh, D. Hunt, J. Jorgensen, C. Martin, M. Richardson, G. Smith, R. Smith, D. Storey, J. Avramovic, J. Croese, J. D'Arcy, S. Fairley, J. Hansen, J. Masson, L. Nathanson, B. O'Loughlin, L. Rutherford, R. Turner, M. Windsor, J. Bessell, P. Devitt, G. Jamieson, D. Watson, S. Blamey, A. Boussioutas, R. Cade, G. Crosthwaite, I. Faragher, J. Gribbin, G. Hebbard, G. Kiroff, B. Mann, R. Millar, P. O'Brien, R. Thomas, S. Wood, S. Archer, K. Faulkner, J. Hamdorf (ACS); R. Stuart-Harris, F. Kirsten, J. Rutovitz, P. Clingan, A.Glasgow, A. Proietto, S. Braye, G. Otton, J. Shannon, T. Bonaventura, J. Stewart, S. Begbie, M. Friedlander, D. Bell, S. Baron-Hay, G. Gard, D. Nevell, N. Pavlakis, S. Valmadre, B. Young, C Camaris, R. Crouch, L. Edwards, N. Hacker, D. Marsden, G. Robertson, P. Beale, J. Beith, J. Carter, C. Dalrymple, R. Houghton, P. Russell, L. Anderson, M. Links, J. Grygiel, J. Hill, A. Brand, K. Byth, R. Jaworski, P. Harnett, R. Sharma,.G Wain, D. Purdie, D. Whiteman, B. Ward, D. Papadimos, A. Crandon, M. Cummings, K. Horwood. A. Obermair, L. Perrin, D. Wyld, J. Nicklin, M. Davy, M. K. Oehler, C. Hall, T. Dodd, T. Healy, K. Pittman, D. Henderson, J. Miller, J. Pierdes, A. Achan, P. Blomfield, D. Challis, R. McIntosh, A. Parker, B. Brown, R. Rome, D. Allen, P. Grant, S. Hyde, R. Laurie, M. Robbie, D. Healy, T. Jobling, T. Manolitsas, J. McNealage, P Rogers, B. Susil, E. Sumithran, I. Simpson, I. Haviv, K. Phillips, D. Rischin, S. Fox, D. Johnson, S. Lade, P. Waring, M. Loughrey, N.O'Callaghan, B. Murray, L. Mileshkin, P. Allan; V. Billson, J. Pyman, D. Neesham, M. Quinn, A. Hamilton, C. Underhill, R. Bell, L. F Ng, R. Blum, V.Ganju, I. Hammond, C. Stewart, Y. Leung, M. Buck, N. Zeps (ACS); G. Peuteman, T. Van Brussel and D. Smeets (BEL); U. Eilber and T. Koehler (GER); L. Gacucova (HMO); P. Schu ̈rmann, F. Kramer, W. Zheng, T.-W. Park-Simon, K. Beer-Grondke and D. Schmidt (HJO); G.S. Keeney, S. Windebank, C. Hilker and J. Vollenweider (MAY); the state cancer registries of AL, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, and WYL (NHS); L. Paddock, M. King, U. Chandran, A. Samoila, and Y. Bensman (NJO); L. Brinton, M. Sherman, A. Hutchinson, N. Szeszenia- Dabrowska, B. Peplonska, W. Zatonski, A. Soni, P. Chao and M. Stagner (POL); ); C. Luccarini, P. Harrington the SEARCH team and ECRIC (SEA); the Scottish Gynaecological Clinical Trails group and SCOTROC1 investigators (SRO); W-H. Chow, Y-T. Gao (SWH); Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov/ (TCGA); I. Jacobs, M. Widschwendter, E. Wozniak, N. Balogun, A. Ryan and J. Ford (UKO); Carole Pye (UKR); a full list of the investigators who contributed to the generation of the WTCCC data is available from http://www.wtccc.org.uk/ (WTCCC). CIMBA (acknowledgements by study) : (BCFR-AU) Maggie Angelakos, Judi Maskiell, Gillian Dite, Helen Tsimiklis. (BCFR-NY) We wish to thank members and participants in the New York site of the Breast Cancer Family Registry for their contributions to the study. (BCFR-ON) We wish to thank members and participants in the Ontario Familial Breast Cancer Registry for their contributions to the study. (BFBOCC-LT) We acknowledge Vilius Rudaitis, Laimonas Gris ˇ kevic ˇ ius, Ramu ̄ nas Janavic ˇ ius (if not in the authorship). BFBOCC-LV acknowledge Drs Janis Eglitis, Anna Krilova and Aivars Stengrevics. (BMBSA) We wish to thank the families who contribute to the BMBSA study. (BRICOH) We wish to thank Yuan Chun Ding and Linda Steele for their work in participant enrolment and biospecimen and data management.(CNIO) We thank Alicia Barroso, Rosario Alonso and Guillermo Pita for their assistance. (CONSIT TEAM) Alessandra Viel and Riccardo Dolcetti of the CRO Aviano National Cancer Institute, Aviano (PN), Italy; Laura Ottini of the 'Sapienza' University, Rome, Italy; Liliana Varesco of the IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy; Laura Papi and Gabriele Capone of the University of Florence, Florence, Italy; Antonella Savarese and Aline Martayan of the Istituto Nazionale Tumori Regina Elena, Rome, Italy; Stefania Tommasi and Brunella Pilato of the Istituto Nazionale Tumori 'Giovanni Paolo II', Bari, Italy. (CORE) The CIMBA data management and analysis is funded through Cancer Research- UK grant C12292/A11174. ACA is a Senior Cancer Research - UK Research Fellow. (EMBRACE) RE is supported by NIHR support to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. (FCCC) We thank Ms. JoEllen Weaver and Dr Betsy Bove for their technical support. (GEMO) Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO) study: National Cancer Genetics Network ) UNICANCER Genetic Group * , France. We wish to thank all the GEMO collaborating groups for their contribution to this study. GEMO Collaborating Centres are: Coordinating Centres, Unite ́ Mixte de Ge ́ ne ́ tique Constitutionnelle des Cancers Fre ́ quents, Hospices Civils de Lyon - Centre Le ́ on Be ́ rard, and Equipe ) Ge ́ ne ́ tique du cancer du sein * , Centre de Recherche en Cance ́ rologie de Lyon: Olga Sinilnikova w , Sylvie Mazoyer, Francesca Damiola, Laure Barjhoux, Carole Verny-Pierre, Me ́ lanie Le ́ one, Nadia Boutry-Kryza, Alain Calender, Sophie Giraud; and Service de Ge ́ ne ́ tique Oncologique, Institut Curie, Paris: Dominique Stoppa-Lyonnet, Marion Gauthier-Villars, Bruno Buecher, Claude Houdayer, Etienne Rouleau, Lisa Golmard, Agne ` s Collet, Virginie Moncoutier, Ce ́ drick Lefol, Muriel Belotti, Antoine de Pauw, Camille Elan, Catherine Nogues, Emmanuelle Fourme, Anne-Marie Birot. Institut Gustave Roussy, Villejuif: Brigitte Bressac-de-Pail- lerets, Olivier Caron, Marine Guillaud-Bataille. Centre Jean Perrin, Clermont–Ferrand: Yves-Jean Bignon, Nancy Uhrhammer. Centre Le ́ on Be ́ rard, Lyon: Christine Lasset, Vale ́ rie Bonadona, Sandrine Handallou. Centre Franc ̧ ois Baclesse, Caen: Agne ` s Hardouin, Pascaline Berthet, Dominique Vaur, Laurent Castera. Institut Paoli Calmettes, Marseille: Hagay Sobol, Violaine Bourdon, Tetsuro Noguchi, Audrey Remenieras, Franc ̧ ois Eisinger. CHU Arnaud-de-Villeneuve, Montpellier: Isabelle Coupier, Pascal Pujol. Centre Oscar Lambret, Lille: Jean-Philippe Peyrat, Joe ̈ lle Fournier, Franc ̧ oise Re ́ villion, Philippe Vennin w , Claude Adenis. Centre Paul Strauss, Strasbourg: Danie ` le Muller, Jean-Pierre Fricker. Institut Bergonie ́ , Bordeaux: Emmanuelle Barouk-Simonet, Franc ̧ oise Bonnet, Virginie Bubien, Nicolas Sevenet, Michel Longy. Institut Claudius Regaud, Toulouse: Christine Toulas, Rosine Guimbaud, Laurence Gladieff, Viviane Feillel. CHU Grenoble: Dominique Leroux, He ́ le ` ne Dreyfus, Christine Rebischung, Magalie Peysselon. CHU Dijon: Fanny Coron, Laurence Faivre. CHU St-Etienne: Fabienne Prieur, Marine Lebrun, Caroline Kientz. Ho ˆ tel Dieu Centre Hospitalier, Chambe ́ ry: Sandra Fert Ferrer. Centre Antoine Lacassagne, Nice: Marc Fre ́ nay. CHU Limoges: Laurence Ve ́ nat-Bouvet. CHU Nantes: Capucine Delnatte. CHU Bretonneau, Tours: Isabelle Mortemousque. Groupe Hospitalier Pitie ́ -Salpe ́ trie ` re, Paris: Florence Coulet, Chrystelle Colas, Florent Soubrier, Mathilde Warcoin. CHU Vandoeuvre-les- Nancy: Johanna Sokolowska, Myriam Bronner. CHU Besanc ̧ on: Marie-Agne ` s Collonge- Rame, Alexandre Damette. Creighton University, Omaha, USA: Henry T. Lynch, Carrie L. Snyder. (G-FAST) We wish to thank the technical support of Ilse Coene en Brecht Crombez. (HCSC) We acknowledge Alicia Tosar for her technical assistance(HEBCS) HEBCS would like to thank Dr Kristiina Aittoma ̈ ki, Taru A. Muranen, Drs Carl Blomqvist and Kirsimari Aaltonen and RNs Irja Erkkila ̈ and Virpi Palola for their help with the HEBCS data and samples. (HEBON) The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) consists of the following Collaborating Centres: Coordinating center: Netherlands Cancer Institute, Amsterdam, NL: M.A. Rookus, F.B.L. Hogervorst, F.E. van Leeuwen, S. Verhoef, M.K. Schmidt, N.S. Russell, J.L. de Lange, R. Wijnands; Erasmus Medical Center, Rotterdam, NL: J.M. Colle ́ e, A.M.W. van den Ouweland, M.J. Hooning, C. Seynaeve, C.H.M. van Deurzen, I.M. Obdeijn; Leiden University Medical Center, NL: C.J. van Asperen, J.T. Wijnen, R.A.E.M. Tollenaar, P. Devilee, T.C.T.E.F. van Cronenburg; Radboud University Nijmegen Medical Center, NL: C.M. Kets, A.R. Mensenkamp; University Medical Center Utrecht, NL: M.G.E.M. Ausems, R.B. van der Luijt, C.C. van der Pol; Amsterdam Medical Center, NL: C.M. Aalfs, T.A.M. van Os; VU University Medical Center, Amsterdam, NL: J.J.P. Gille, Q. Waisfisz, H.E.J. Meijers-Heijboer; University Hospital Maastricht, NL: E.B. Go ́ mez- Garcia, M.J. Blok; University Medical Center Groningen, NL: J.C. Oosterwijk, A.H. van der Hout, M.J. Mourits, G.H. de Bock; The Netherlands Foundation for the detection of hereditary tumours, Leiden, NL: H.F. Vasen; The Netherlands Comprehensive Cancer Organization (IKNL): S. Siesling, J.Verloop; The Dutch Pathology Registry (PALGA): L.I.H. Overbeek. The HEBON study is supported by the Dutch Cancer Society grants NKI1998-1854, NKI2004-3088, NKI2007-3756, the Netherlands Organization of Scien- tific Research grant NWO 91109024, the Pink Ribbon grants 110005 and 2014- 187.WO76, the BBMRI grant NWO 184.021.007/CP46 and the Transcan grant JTC 2012 Cancer 12-054. HEBON thanks the registration teams of IKNL and PALGA for part of the data collection. (HRBCP) We wish to thank Hong Kong Sanatoriuma and Hospital for their continual support. (HUNBOCS) We wish to thank the Hungarian Breast and Ovarian Cancer Study Group members (Janos Papp, Tibor Vaszko, Aniko Bozsik, Timea Pocza, Judit Franko, Maria Balogh, Gabriella Domokos, Judit Ferenczi, Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary) and the clin- icians and patients for their contributions to this study.(HVH) We wish to thank the Oncogenetics Group (VHIO), and the High Risk and Cancer Prevention Unit of the University Hospital Vall d'Hebron.(ICO) We wish to thank the ICO Hereditary Cancer Program team led by Dr Gabriel Capella. (INHERIT) We would like to thank Dr Martine Dumont, Martine Tranchant for sample management and skilful technical assistance. J.S. is Chairholder of the Canada Research Chair in Oncogenetics. J.S. and P.S. were part of the QC and Genotyping coordinating group of iCOGS (BCAC and CIMBA). (IPOBCS) We wish to thank Drs Ana Peixoto, Catarina Santos, Patrı ́ cia Rocha and Pedro Pinto for their skilful contribution to the study. (KCONFAB) We wish to thank Heather Thorne, Eveline Niedermayr, all the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics, and the Clinical Follow Up Study (which has received funding from the NHMRC, the National Breast Cancer Foundation, Cancer Australia, and the National Institute of Health (USA)) for their contributions to this resource, and the many families who contribute to kConFab. (MODSQUAD) Modifier Study of Quantitative Effects on Disease (MODSQUAD): we acknowledge ModSQuaD members Csilla Szabo (National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA); Lenka Foretova and Eva Machackova (Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, Brno, Czech Republic); and Michal Zikan, Petr Pohlreich and Zdenek Kleibl (Oncogynecologic Center and Department of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic). (MSKCC) Anne Lincoln, Lauren Jacobs. (NICCC) We wish to thank the NICCC National Familial Cancer Consultation Service team led by Sara Dishon, the lab team led by Dr Flavio Lejbkowicz, and the research field operations team led by Dr Mila Pinchev. (NRG Oncology) We thank the investigators of the Australia New Zealand NRG Oncology group. (OCGN) We wish to thank members and participants in the Ontario Cancer Genetics Network for their contributions to the study. (OSU CCG) Leigha Senter, Kevin Sweet, Caroline Craven, and Michelle O'Conor were instrumental in accrual of study participants, ascertainment of medical records and database management. Samples were processed by the OSU Human Genetics Sample Bank. (SEABASS) We would like to thank Yip Cheng Har, Nur Aishah Mohd Taib, Phuah Sze Yee, Norhashimah Hassan and all the research nurses, research assistants and doctors involved in the MyBrCa Study for assistance in patient recruitment, data collection and sample preparation. In addition, we thank Philip Iau, Sng Jen-Hwei and Sharifah Nor Akmal for contributing samples from the Singapore Breast Cancer Study nd the HUKM-HKL Study respectively. The Malaysian Breast Cancer Genetic Study is funded by research grants from the Malaysian Ministry of Science, Technology and Innovation, Ministry of Higher Education (UM.C/HIR/MOHE/06) and charitable funding from Cancer Research Initiatives Foundation. (SMC) SMC team wishes to acknowledge the assistance of the Meirav Comprehensice breast cancer center team at the Sheba Medical Center for assistance in this study. (SWE-BRCA) Swedish scientists participating as SWE-BRCA collaborators are: from Lund University and University Hospital: Åke Borg, Håkan Olsson, Helena Jernstro ̈ m, Karin Henriksson, Katja Harbst, Maria Soller, Ulf Kristoffersson; from Gothenburg Sahlgrenska University Hospital: Anna O ̈ fverholm, Margareta Nordling, Per Karlsson, Zakaria Einbeigi; from Stockholm and Karolinska University Hospital: Anna von Wachenfeldt, Annelie Liljegren, Annika Lindblom, Brita Arver, Gisela Barbany Bustinza, Johanna Rantala; from Umeå University Hospital: Beatrice Melin, Christina Edwinsdotter Ardnor, Monica Emanuelsson; from Uppsala University: Hans Ehrencrona, Maritta Hellstro ̈ m Pigg, Richard Rosenquist; from Linko ̈ ping University Hospital: Marie Stenmark-Askmalm, Sigrun Lied- gren(UCHICAGO) We wish to thank Cecilia Zvocec, Qun Niu, physicians, genetic counsellors, research nurses and staff of the Cancer Risk Clinic for their contributions to this resource, and the many families who contribute to our programme. (UCLA) We thank Joyce Seldon MSGC and Lorna Kwan, MPH for assembling the data for this study. (UCSF) We would like to thank Dr Robert Nussbaum and the following genetic coun- sellors for participant recruitment: Beth Crawford, Kate Loranger, Julie Mak, Nicola Stewart, Robin Lee, Amie Blanco and Peggy Conrad. And thanks to Ms. Salina Chan for her data management. (UKFOCR) We thank Carole Pye, Patricia Harrington and Eva Wozniak for their contributions towards the UKFOCR. (VFCTG) Geoffrey Lindeman, Marion Harris, Martin Delatycki of the Victorian Familial Cancer Trials Group. We thank Sarah Sawyer and Rebecca Driessen for assembling this data and Ella Thompson for performing all DNA amplification. Grant Support : The COGS project is funded through a European Commission's Seventh Framework Programme grant (agreement number 223175—HEALTH-F2-2009- 223175). BCAC is funded by Cancer Research UK [C1287/A10118, C1287/A12014] and by the European Community ́ s Seventh Framework Programme under grant agreement number 223175 (grant number HEALTH-F2-2009-223175) (COGS). The CIMBA data management and analytical work is funded by Cancer Research UK (C12292/A11174, C12292/A20861). Funding for the iCOGS infrastructure came from: the European Community's Seventh Framework Programme under grant agreement n ° 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565), the National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 - the GAME-ON initiative), the Department of Defence (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure, the Breast Cancer Research Foundation, and the Ovarian Cancer Research Fund. The Ovarian Cancer Association Consortium is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). The scientific development and funding for this project were in part supported by the US National Cancer Institute GAME-ON Post-GWAS Initiative (U19-CA148112). This study made use of data generated by the Wellcome Trust Case Control consortium. Funding for the project was provided by the Wellcome Trust under award 076113. The results published here are in part based on data generated by The Cancer Genome Atlas Project established by the National Cancer Institute and National Human Genome Research Institute. Personal support: K.L. is supported by a K99/R00 grant from the National Cancer Institute (Grant number 1K99CA184415-01). This project was supported in part by a Program Project Development Grant from the Ovarian Cancer Research Fund (S.A.G and A.M). The in vitro aspects of this project were performed within the Norris Cancer Centre at USC, which is supported in part by award number P30CA014089 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. D.F.E. is a Principal Research Fellow of Cancer Research UK. A.C.A. is a Cancer Research—UK Senior Cancer Research Fellow. G.C.-T. and P.M.W. are supported by the National Health and Medical Research Council. (WCP) B.Y.K is funded by the American Cancer Society Early Detection Professorship (SIOP- 06-258-01-COUN) and the National Center for Advancing Translational Sciences (NCATS), Grant UL1TR000124. L.E.K. is supported by a Canadian Institutes of Health Research Investigator award (MSH-87734). S.P.K. is supported by a Gates Cambridge Scholarship. J.S. is Chairholder of the Canada Research Chair in Oncogenetics. RB was a Cancer Institute NSW Clinical Research Fellow. M.C.S. is a NHMRC Senior Research Fellow. A.K.G. was funded by 5U01CA113916, R01CA140323, and by the Chancellors Distinguished Chair in Biomedical Sciences Professorship. J.L.H. is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow. S.L.E. and J.D.F. are supported by Fellowships from the National Breast Cancer Foundation (NBCF) Australia and NHMRC project grant (1058415). Funding : BCAC: The Australian Breast Cancer Family Study (ABCFS) was supported by grant UM1 CA164920 from the National Cancer Institute (USA). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centres in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. The ABCFS was also supported by the National Health and Medical Research Council of Australia, the New South Wales Cancer Council, the Victorian Health Promotion Foundation (Australia) and the Victorian Breast Cancer Research Consortium. The ABCS study was supported by the Dutch Cancer Society [grants NKI 2007-3839; 2009 4363]. The ACP study is funded by the Breast Cancer Research Trust, UK. The BBCS is funded by Cancer Research UK and Breakthrough Breast Cancer and acknowledges NHS funding to the NIHR Biomedical Research Centre, and the National Cancer Research Network (NCRN).ES is supported by NIHR Comprehensive Biomedical Research Centre, Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London, United Kingdom. IT is supported by the Oxford Biomedical Research Centre.The BSUCH study was supported by the Dietmar-Hopp Foundation, the Helmholtz Society and the German Cancer Research Center (DKFZ). The CGPS was supported by the Chief Physician Johan Boserup and Lise Boserup Fund, the Danish Medical Research Council and Herlev HospitalThe CNIO-BCS was supported by the Instituto de Salud Carlos III, the Red Tema ́ tica de Investigacio ́ n Cooperativa en Ca ́ ncer and grants from the Asociacio ́ n Espan ̃ ola Contra el Ca ́ ncer and the Fondo de Investigacio ́ n Sanitario (PI11/00923 and PI12/00070). The CTS was initially supported by the California Breast Cancer Act of 1993 and the California Breast Cancer Research Fund (contract 97-10500) and is cur- rently funded through the National Institutes of Health (R01 CA77398). Collection of cancer incidence data was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885. HAC receives support from the Lon V Smith Foundation (LVS39420). The ESTHER study was supported by a grant from the Baden Wu ̈rttemberg Ministry of Science, Research and Arts. Additional cases were recruited in the context of the VERDI study, which was supported by a grant from the German Cancer Aid (Deutsche Krebshilfe). The GC-HBOC was supported by Deutsche Krebshilfe (107 352). The GENICA was funded by the Federal Ministry of Education and Research (BMBF) Germany grants 01KW9975/5, 01KW9976/8, 01KW9977/0 and 01KW0114, the Robert Bosch Foundation, Stuttgart, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, the Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, as well as the Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany. The HEBCS was financially supported by the Helsinki University Central Hospital Research Fund, Academy of Finland (266528), the Finnish Cancer Society, The Nordic Cancer Union and the Sigrid Juselius Foundation. The HMBCS was supported by a grant from the Friends of Hannover Medical School and by the Rudolf Bartling Foundation. The KBCP was financially supported by the special Government Funding (EVO) of Kuopio University Hospital grants, Cancer Fund of North Savo, the Finnish Cancer Organizations, and by the strategic funding of the University of Eastern Finland. kConFab is supported by a grant from the National Breast Cancer Foundation, and previously by the National Health and Medical Research Council (NHMRC), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. Financial support for the AOCS was provided by the United States Army Medical Research and Materiel Command [DAMD17-01-1-0729], Cancer Council Victoria, Queensland Cancer Fund, Cancer Council New South Wales, Cancer Council South Australia, The Cancer Foundation of Western Australia, Cancer Council Tasmania and the National Health and Medical Research Council of Australia (NHMRC; 400413, 400281, 199600). LAABC is supported by grants (1RB-0287, 3PB-0102, 5PB-0018, 10PB-0098) from the California Breast Cancer Research Program. Incident breast cancer cases were collected by the USC Cancer Surveillance Program (CSP), which is supported under subcontract by the California Department of Health. The CSP is also part of the National Cancer Institute's Division of Cancer Prevention and Control Surveillance, Epidemiology, and End Results Program, under contract number N01CN25403. LMBC is supported by the 'Stichting tegen Kanker' (232-2008 and 196-2010). Diether Lambrechts is supported by the FWO and the KULPFV/10/016-SymBioSysII.The MARIE study was supported by the Deutsche Krebshilfe e.V. [70-2892-BR I, 106332, 108253, 108419], the Hamburg Cancer Society, the German Cancer Research Center (DKFZ) and the Federal Ministry of Education and Research (BMBF) Germany [01KH0402]. (MBCSG) is supported by grants from the Italian Association for Cancer Research (AIRC) and by funds from the Italian citizens who allocated the 5/1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects '5x1000'). The work of MTLGEBCS was supported by the Quebec Breast Cancer Foundation, the Canadian Institutes of Health Research for the 'CIHR Team in Familial Risks of Breast Cancer' program – grant # CRN-87521 and the Ministry of Economic Development, Innovation and Export Trade – grant # PSR-SIIRI-701.MYBRCA is funded by research grants from the Malaysian Ministry of Science, Technology and Innovation (MOSTI), Malaysian Ministry of Higher Education (UM.C/HlR/MOHE/06) and Cancer Research Initiatives Foundation (CARIF). Additional controls were recruited by the Singapore Eye Research Institute, which was supported by a grant from the Biomedical Research Council (BMRC08/1/35/19/550), Singapore and the National medical Research Council, Singa- pore (NMRC/CG/SERI/2010). The NBHS was supported by NIH grant R01CA100374. Biological sample preparation was conducted the Survey and Biospecimen Shared Resource, which is supported by P30 CA68485. The OBCS was supported by research grants from the Finnish Cancer Foundation, the Academy of Finland (grant number 250083, 122715 and Center of Excellence grant number 251314), the Finnish Cancer Foundation, the Sigrid Juselius Foundation, the University of Oulu, the University of Oulu Support Foundation and the special Governmental EVO funds for Oulu University Hospital-based research activities. The Ontario Familial Breast Cancer Registry (OFBCR) was supported by grant UM1 CA164920 from the National Cancer Institute (USA). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centres in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. The ORIGO study was supported by the Dutch Cancer Society (RUL 1997-1505) and the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL CP16). The PBCS was funded by Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA. The pKARMA study was supported by Ma ̈ rit and Hans Rausings Initiative Against Breast CancerThe RBCS was funded by the Dutch Cancer Society (DDHK 2004-3124, DDHK 2009-4318). The SASBAC study was sup- ported by funding from the Agency for Science, Technology and Research of Singapore (A*STAR), the US National Institute of Health (NIH) and the Susan G. Komen Breast Cancer Foundation. The SBCGS was supported primarily by NIH grants R01CA64277, R01CA148667, and R37CA70867. Biological sample preparation was conducted the Survey and Biospecimen Shared Resource, which is supported by P30 CA68485. The scientific development and funding of this project were, in part, supported by the Genetic Associations and Mechanisms in Oncology (GAME-ON) Network U19 CA148065.The SBCS was supported by Yorkshire Cancer Research S295, S299, S305PA and Sheffield Experimental Cancer Medicine Centre.SEARCH is funded by a programme grant from Cancer Research UK [C490/A10124] and supported by the UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge.SGBCC is funded by the NUS start-up Grant, National University Cancer Institute Singapore (NCIS) Centre Grant and the NMRC Clinician Scientist Award. Additional controls were recruited by the Singapore Consortium of Cohort Studies-Multi-ethnic cohort (SCCS-MEC), which was funded by the Biomedical Research Council, grant number: 05/ 1/21/19/425.SKKDKFZS is supported by the DKFZ. The TNBCC was supported by: a Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), a grant from the Breast Cancer Research Foundation, a generous gift from the David F. and Margaret T. Grohne Family Foundation, the Hellenic Cooperative Oncology Group research grant (HR R_BG/04) and the Greek General Secretary for Research and Technology (GSRT) Program, Research Excellence II, the European Union (European Social Fund – ESF), and Greek national funds through the Operational Program 'Education and Lifelong Learning' of the National Strategic Reference Framework (NSRF) - ARISTEIA. The UKBGS is funded by Breakthrough Breast Cancer and the Institute of Cancer Research (ICR), London. ICR acknowledges NHS funding to the NIHR Biomedical Research Centre. Funding : OCAC : Funding of the constituent studies was provided by the American Cancer Society (CRTG-00-196-01-CCE); the California Cancer Research Program (00-01389 V-20170, N01-CN25403, 2II0200); the Canadian Institutes for Health Research (MOP-86727); Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; the Cancer Institute of New Jersey; Cancer Research UK (C490/A6187, C490/A10119, C490/A10124, C536/A13086, C536/A6689); the Celma Mastry Ovarian Cancer Foundation; the Danish Cancer Society (94-222-52); the ELAN Program of the University of Erlangen-Nuremberg; the Eve Appeal; the Helsinki University Central Hospital Research Fund; Helse Vest; Imperial Experimental Cancer Research Centre (C1312/A15589); the Norwegian Cancer Society; the Norwegian Research Council; the Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health Labour and Welfare of Japan; the L and S Milken Foun- dation; the Polish Ministry of Science and Higher Education (4 PO5C 028 14, 2 PO5A 068 27); Malaysian Ministry of Higher Education (UM.C/HlR/MOHE/06) and Cancer Research Initiatives Foundation; the Roswell Park Cancer Institute Alliance Foundation; the US National Cancer Institute (K07-CA095666, K07-CA143047, K22-CA138563, N01-CN55424, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P30-CA15083, P50-CA105009, P50- CA136393, R01-CA014089, R01-CA016056, R01-CA017054, R01-CA049449, R01-CA050385, R01-CA054419, R01- CA058598, R01-CA058860, R01-CA061107, R01-CA061132, R01-CA063682, R01-CA064277, R01-CA067262, R01- CA071766, R01-CA074850, R01-CA076016, R01-CA080742, R01-CA080978, R01-CA083918, R01-CA087538, R01- CA092044, R01-095023, R01-CA106414, R01-CA122443, R01-CA112523, R01-CA114343, R01-CA126841, R01- CA136924, R01-CA149429, R03-CA113148, R03-CA115195, R37-CA070867, R37-CA70867, U01-CA069417, U01- CA071966, R01-CA063678 and Intramural research funds); the US Army Medical Research and Material Command (DAMD17-98-1- 8659, DAMD17-01-1-0729, DAMD17-02-1-0666, DAMD17-02-1- 0669, W81XWH-10-1-0280); the National Health and Medical Research Council of Australia (199600 and 400281); the German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research (01 GB 9401); the state of Baden-Wu ̈rttemberg through Medical Faculty of the University of Ulm (P.685); the Minnesota Ovarian Cancer Alliance; the Mayo Foundation; the Fred C. and Katherine B. Andersen Foundation; the Lon V. Smith Foundation (LVS-39420); the Oak Foundation; the OHSU Foundation; the Mermaid I project; the Rudolf-Bartling Foundation; the UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge, Imperial College London, University College Hospital 'Womens Health Theme' and the Royal Marsden Hospital; WorkSafeBC. Funding : CIMBA (BCFR—all) : This work was supported by grant UM1 CA164920 from the National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centres in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the BCFR. (BFBOCC-LT) BFBOCC is partly supported by: Lithuania (BFBOCC-LT): Research Council of Lithuania grant LIG-07/2012; (BIDMC) BIDMC is supported by the Breast Cancer Research Foundation. (BMBSA) BRCA-gene mutations and breast cancer in South African women (BMBSA) was supported by grants from the Cancer Association of South Africa (CANSA) to Elizabeth J. van Rensburg. (BRICOH) SLN was partially supported by the Morris and Horowitz Familes Endowed Professorship. (CBCS) This work was supported by the NEYE Foundation. (CNIO) This work was partially supported by Spanish Association against Cancer (AECC08), RTICC 06/0020/1060, FISPI08/1120, Mutua Madrilen ̃ a Foundation (FMMA) and SAF2010-20493 (COH-CCGCRN) City of Hope Clinical Cancer Genetics Community Network and the Hereditary Cancer Research Registry, supported in part by Award Number RC4CA153828 (PI: J. Weitzel) from the National Cancer Institute and the Office of the Director, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. (CONSIT TEAM) Funds from Italian citizens who allocated the 5x1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects '5x1000') to Siranoush Manoukian. (CORE) The CIMBA data management and data analysis were supported by Cancer Research – UK grants C12292/A11174 and C1287/A10118.SH is supported by an NHMRC Program Grant to GCT. ACA is a Cancer Research -UK Senior Cancer Research Fellow. (DEMOKRITOS) This research has been co-financed by the European Union (European Social Fund – ESF) and Greek national funds through the Operational Program 'Education and Lifelong Learning' of the National Strategic Reference Frame- work (NSRF) - Research Funding Program of the General Secretariat for Research and Technology: ARISTEIA. Investing in knowledge society through the European Social Fund.(DKFZ) The DKFZ study was supported by the DKFZ. (EMBRACE) EMBRACE is supported by Cancer Research UK Grants C1287/A10118 and C1287/A11990. D. Gareth Evans and Fiona Lalloo are supported by an NIHR grant to the Biomedical Research Centre, Manchester. The Investigators at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust are supported by an NIHR grant to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. (FCCC) The authors acknowledge support from The University of Kansas Cancer Center (P30 CA168524) and the Kansas Bioscience Authority Eminent Scholar Program. (GC-HBOC) The German Consortium of Hereditary Breast and Ovarian Cancer (GC-HBOC) is supported by the German Cancer Aid (grant no 109076, Rita K. Schmutzler) and by the Center for Molecular Medicine Cologne (CMMC). (GEMO) The study was supported by the Ligue Nationale Contre le Cancer; the Association 'Le cancer du sein, parlons-en!' Award; the Canadian Institutes of Health Research for the 'CIHR Team in Familial Risks of Breast Cancer' program and the French National Institute of Cancer (INCa). (GEORGETOWN) CI received support from the Non-Therapeutic Subject Registry Shared Resource at Georgetown University (NIH/NCI grant P30-CA051008), the Fisher Center for Familial Cancer Research, and Swing Fore the Cure. (G-FAST) Kim De Leeneer is supported by GOA grant BOF10/ GOA/019 (Ghent University) and spearhead financing of Ghent University Hospital. (HCSC) HCSC supported by a grant RD12/0036/0006 and 12/00539 from ISCIII (Spain), partially supported by European Regional Development FEDER funds. (HEBCS) The HEBCS was financially supported by the Helsinki University Hospital Research Fund, Academy of Finland (266528), the Finnish Cancer Society and the Sigrid Juselius Foundation. (HEBON) The HEBON study is supported by the Dutch Cancer Society grants NKI1998-1854, NKI2004-3088, NKI2007-3756, the Netherlands Organization of Scientific Research grant NWO 91109024, the Pink Ribbon grant 110005 and the BBMRI grant NWO 184.021.007/CP46. HEBON thanks the registration teams of the Comprehensive Cancer Centre Netherlands and Comprehensive Centre South (together the Netherlands Cancer Registry) and PALGA (Dutch Pathology Registry) for part of the data collection. (HRBCP) HRBCP is supported by The Hong Kong Hereditary Breast Cancer Family Registry and the Dr Ellen Li Charitable Foundation, Hong Kong (HUNBOCS) Hungarian Breast and Ovarian Cancer Study was supported by Hungarian Research Grants KTIA-OTKA CK-80745, OTKA K-112228 and the Norwegian EEA Financial Mechanism Hu0115/NA/2008-3/OP-9. (ICO) Contract grant sponsor: Asociacio ́ n Espan ̃ ola Contra el Ca ́ ncer, Spanish Health Research Fund; Carlos III Health Institute; Catalan Health Institute and Autonomous Government of Catalonia. Contract grant numbers: ISCIIIRETIC RD06/0020/1051, RD12/0036/008, PI10/01422, PI10/ 00748, PI13/00285, PIE13/00022, 2009SGR290 and 2014SGR364. (IHCC) The IHCC was supported by Grant PBZ_KBN_122/P05/2004(ILUH) The ILUH group was supported by the Icelandic Association 'Walking for Breast Cancer Research' and by the Landspitali University Hospital Research Fund. (INHERIT) This work was supported by the Canadian Institutes of Health Research for the 'CIHR Team in Familial Risks of Breast Cancer' program, the Canadian Breast Cancer Research Alliance-grant #019511 and the Ministry of Economic Development, Innovation and Export Trade – grant # PSR-SIIRI- 701. (IOVHBOCS) IOVHBOCS is supported by Ministero della Salute and '5 1,000' Istituto Oncologico Veneto grant. (IPOBCS) This study was in part supported by Liga Portuguesa Contra o Cancro.(KCONFAB) kConFab is supported by a grant from the National Breast Cancer Foundation, and previously by the National Health and Medical Research Council (NHMRC), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia; (KOHBRA) KOHBRA is supported by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs,Republic of Korea (1020350). (MAYO) MAYO is supported by NIH grants CA116167, CA128978 and CA176785, an NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), a U.S. Department of Defence Ovarian Cancer Idea award (W81XWH-10-1-0341), a grant from the Breast Cancer Research Foundation, a generous gift from the David F. and Margaret T. Grohne Family Foundation and the Ting Tsung and Wei Fong Chao Foundation. (MCGILL) Jewish General Hospital Weekend to End Breast Cancer, Quebec Ministry of Economic Development, Innovation and Export Trade (MODSQUAD) MODSQUAD was supported by MH CZ - DRO (MMCI, 00209805) and by the European Regional Development Fund and the State Budget of the Czech Republic (RECAMO, CZ.1.05/2.1.00/03.0101) to LF, and by Charles University in Prague project UNCE204024 (MZ). (MSKCC) MSKCC is supported by grants from the Breast Cancer Research Foundation, the Robert and Kate Niehaus Clinical Cancer Genetics Initiative, and the Andrew Sabin Research Fund. (NAROD) 1R01 CA149429- 01. (NCI) The research of Drs MH Greene, JT Loud and PL Mai was supported by the Intramural Research Program of the US National Cancer Institute, NIH, and by support services contracts NO2-CP-11019-50 and N02-CP-65504 with Westat, Inc, Rockville, MD. (NICCC) NICCC is supported by Clalit Health Services in Israel. Some of it's activities are supported by the Israel Cancer Association and the Breast Cancer Research Foundation (BCRF), NY. (NNPIO) This work has been supported by the Russian Federation for Basic Research (grants 13-04-92613, 14-04-93959 and 15-04-01744). (NRG Oncology) This study was supported by National Cancer Institute grants to the NRG Oncology Administrative Office and Tissue Bank (CA 27469), the NRG Oncology Statistical and Data Center (CA 37517), and NRG Oncology's Cancer Prevention and Control Committee (CA 101165). (OSU CCG) OSUCCG is supported by the Ohio State University Comprehensive Cancer Center. (PBCS) This work was supported by the ITT (Istituto Toscano Tumori) grants 2011-2013. (SEABASS) Ministry of Science, Technol- ogy and Innovation, Ministry of Higher Education (UM.C/HlR/MOHE/06) and Cancer Research Initiatives Foundation. (SMC) This project was partially funded through a grant by the Isreal cancer association and the funding for the Israeli Inherited breast cancer consortium (SWE-BRCA) SWE-BRCA collaborators are supported by the Swedish Cancer Society. (UCHICAGO) UCHICAGO is supported by NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA125183), R01 CA142996, 1U01CA161032 and by the Ralph and Marion Falk Medical Research Trust, the Entertainment Industry Fund National Women's Cancer Research Alliance and the Breast Cancer research Foundation. OIO is an ACS Clinical Research Professor.(UCLA) Jonsson Comprehensive Cancer Center Foundation; Breast Cancer Research Foundation. (UCSF) UCSF Cancer Risk Program and Helen Diller Family Comprehensive Cancer Center. (UKFOCR) UKFOCR was supported by a project grant from CRUK to Paul Pharoah. (UPENN) National Institutes of Health (NIH) (R01-CA102776 and R01- CA083855; Breast Cancer Research Foundation; Susan G. Komen Foundation for the cure, Basser Research Center for BRCA. (UPITT/MWH) Frieda G. and Saul F. Shapira BRCA-Associated Cancer Research Program;Hackers for Hope Pittsburgh. (VFCTG) Victorian Cancer Agency, Cancer Australia, National Breast Cancer Foundation unding for the iCOGS infrastructure came from: the European Community's Seventh Framework Programme under grant agreement n ° 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118, C1287/A 10710, C12292/A11174, C1281/ A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565), the National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 - the GAME-ON initiative), the Department of Defence (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure, the Breast Cancer Research Foundation, and the Ovarian Cancer Research Fund and grants R01-CA122443 and P50-CA136393. ; Sí